Edgar Filing: ENVIRO VORAXIAL TECHNOLOGY INC

As filed with the Securities and Exchange Commission on February 27, 2007
Registration No. _____________

================================================================================
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549

-----------------

FORM SB-2
REGISTRATION STATEMENT
UNDER THE
SECURITIES ACT OF 1933

-----------------

ENVIRO VORAXIAL TECHNOLOGY, INC.
--------------------------------
(Name of Small Business Issuer in Its Charter)

Idaho 3559 82-0266517
----- ---- ----------
(State or Other Jurisdiction of (Primary Standard Industrial (I.R.S. Employer
Incorporation or Organization) Classification Number) Identification No.)

821 NW 57th Place
Fort Lauderdale, FL 33309
(954) 958-9968
(Address and Telephone Number of Principal Executive Offices)

-----------------

A. DiBella, Chief Executive Officer
821 NW 57th Place
Fort Lauderdale, FL 33309
(954) 958-9968
(Name, Address and Telephone Number of Agent for Service)

-----------------

Copies of all communications to:

Brian A. Pearlman, Esq.
Arnstein & Lehr LLP
200 East Las Olas Boulevard, Suite 1700
Fort Lauderdale, Florida 33301
Telephone: (954) 713-7600
Facsimile No. (954) 713-7700

-----------------

Approximate Date of Proposed Sale to the Public: As soon as practicable
after the effective date of this Registration Statement.

We hereby amend this Registration Statement on such date or dates as
may be necessary to delay its effective date until we file a further amendment
which specifically states that this Registration Statement shall thereafter
become effective in accordance with Section 8(a) of the Securities Act of 1933,
as amended, or until the Registration Statement shall become effective on such
date as the Securities and Exchange Commission, acting under Section 8(a), may
determine.

If this Form is filed to register additional securities for an offering
pursuant to Rule 462(b) under the Securities Act, please check the following box
and list the Securities Act registration statement number of the earlier
effective registration statement for the same offering. [ ]

If this Form is a post-effective amendment filed pursuant to Rule
462(c) under the Securities Act, check the following box and list the Securities
Act registration statement number of the earlier effective registration
statement for the same offering. [ ]

If this Form is a post-effective amendment filed pursuant to Rule
462(d) under the Securities Act, check the following box and list the Securities
Act registration number of the earlier effective registration statement for the
same offering. [ ]

If delivery of the prospectus is expected to be made pursuant to Rule
434, please check the following box. [ ]

-----------------

CALCULATION OF REGISTRATION FEE

Proposed Proposed
Title of Each Maximum Maximum Amount of
Class of Securities Amount to be Offering Price Aggregate Registration
to be Registered Registered Per Security Offering Price Fee
---------------- ---------- ------------ -------------- ---

Common stock, par value $0.001 per share(1)...... 265,250 $0.75 $198,937.50 6.11
4,213,581 $1.00 $4,213,581.00 129.36
516,666 $1.25 $645,832.50 19.83
100,000 $3.00 $300,000.00 9.21
100,000 $4.00 $400,000.00 12.28
121,600 $6.00 $729,600.00 22.40
121,600 $9.00 $1,094,400.00 33.60
697,333 $0.60 $418,399.80 12.84
30,000 $0.71 $21,300.00 0.65
200,000 $0.77 $154,000.00 4.73
150,000 $0.80 $120,000.00 3.68
225,000 $0.80 $180,000.00 5.53
757,333 $1.00 $757,333.00 23.25
Common stock, par value $0.001 per share(2)...... 2,000,000 $0.15 $300,000.00(2) 9.21
45,000 $0.30 $13,500.00(2) 0.41

Total Registration Fee $9,546,883.80 $ 293.09

-----------------
(1) Estimated solely for purposes of calculating the registration fee
pursuant to Rule 457(g). Shares issuable upon exercise of warrants and
options based upon the exercise price of the respective option or
warrant, which is higher than the closing price for the common stock on
February 23, 2007.
(2) Estimated solely for purposes of calculating the registration fee
pursuant to Rule 457(g). Shares issuable upon exercise of warrants and
options. Based upon the closing price for the common stock on February
23, 2007 ($0.54 as reported on the OTCBB), which is higher than the
exercise price of the respective option or warrant.
-----------------

Information contained herein is subject to completion or amendment. A
registration statement relating to these securities has been filed with the
Securities and Exchange Commission. These securities may not be sold nor may
offers to buy be accepted prior to the time the registration statement becomes
effective. This prospectus shall not constitute an offer to sell or the
solicitation of an offer to buy nor shall there by any sale of these securities
in any state in which such offer, solicitation or sale would be unlawful prior
to registration or qualification under the securities laws of any such state.

The information in this prospectus is not complete and may be changed. We may
not sell these securities until the registration statement filed with the
Securities and Exchange Commission is effective. This prospectus is not an offer
to sell the securities and it is not soliciting an offer to buy these securities
in any state where the offer or sale is not permitted.

================================================================================
SUBJECT TO COMPLETION: DATED FEBRUARY __, 2007

PROSPECTUS

ENVIRO VORAXIAL TECHNOLOGY, INC.

9,543,363 SHARES

This prospectus covers 9,543,363 shares of common stock of Enviro
Voraxial Technology, Inc. being offered for resale by certain selling
shareholders. All of these shares represent shares underlying outstanding
options and warrants. We are paying the expenses incurred in registering the
shares, which may be offered by the selling shareholders, but all selling and
other expenses incurred by the shareholders will be borne by the selling
shareholders.

The securities may be sold by the shareholders to or through
underwriters or dealers, directly to purchasers or through agents designated
from time to time. For additional information on the methods of sale, you should
refer to the section entitled "Plan of Distribution" in this prospectus.

Our common stock is quoted on the OTCBB under the trading symbol
"EVTN". Prior to the date of this prospectus there has been limited trading
activity for our common stock and the market for our shares has been illiquid.
On January 30, 2007, the closing price for our common stock was $0.45.

THIS INVESTMENT INVOLVES A HIGH DEGREE OF RISK. YOU SHOULD PURCHASE SHARES ONLY
IF YOU CAN AFFORD A COMPLETE LOSS OF YOUR INVESTMENT. SEE "RISK FACTORS"
BEGINNING ON PAGE 3.

NEITHER THE SECURITIES AND EXCHANGE COMMISSION NOR ANY STATE SECURITIES
COMMISSION HAS APPROVED OR DISAPPROVED THESE SECURITIES, OR DETERMINED IF THIS
PROSPECTUS IS TRUTHFUL OR COMPLETE. ANY REPRESENTATION TO THE CONTRARY IS A
CRIMINAL OFFENSE.

PROSPECTUS SUMMARY

This summary contains what we believe is the most important information
about us and the offering. You should read the entire document for a complete
understanding of our business and the transactions in which we are involved. The
purchase of the securities offered by this prospectus involves a high degree of
risk. See the "Risk Factors" section of this prospectus for risk factors. Unless
otherwise indicated, information in this prospectus (excluding our financial
statements) gives effect to our recent offerings.

INDUSTRY DATA

Information contained in this prospectus concerning our industry, the
markets for our products and the historic growth rate of, and our position in,
those markets, is based on estimates that we prepared using data from various
sources (including industry publications, surveys and forecasts and our internal
research), on assumptions that we have made that are based on that data and
other similar sources and our knowledge of the markets for our products. We take
responsibility for compiling and extracting, but have not independently
verified, market and industry data provided by third parties, or by industry or
general publications. Similarly, while we believe our internal estimates are
reliable, our estimates have not been verified by any independent sources, and
we cannot assure you as to their accuracy.

DESCRIPTION OF BUSINESS

Enviro Voraxial Technology, Inc. (the "Company") was incorporated in
Idaho on October 19, 1964. In May of 1996, we entered into an agreement and plan
of reorganization with a privately held Florida corporation, Florida Precision
Aerospace, Inc. ("FPA"), and its shareholders. FPA was incorporated on February
26, 1993. We exchanged approximately 97% of our shares then issued and
outstanding for all of the issued and outstanding shares of FPA. As a result of
this reorganization, the shareholders of FPA gained control of our company and
FPA became our wholly owned subsidiary. At the close of the transaction, we
changed our name to Enviro Voraxial Technology, Inc. Our executive offices are
located at 821 N.W. 57th Place, Fort Lauderdale, Florida 33309. Our telephone
number is 954-958-9968.

The Voraxial(R) Separator is a continuous flow turbo machine that
generates a strong centrifugal force, a vortex, capable of separating light and
heavy liquids, such as oil and water, or any other combination of liquids and
solids at extremely high flow rates. As the fluid passes through the machine,
the Voraxial(R) Separator accomplishes this separation through the creation of a
vortex. In liquid/liquid and liquid/solid mixtures, this vortex causes the
heavier compounds to gravitate to the outside of the flow and the lighter
elements to move to the center where an inner core is formed. The liquid stream
processed by the machine is divided into separate streams of heavier and lighter
liquids and solids. As a result of this process, separation is achieved.

To date we have had limited revenues and have an accumulated deficit at
September 30, 2006 of $6,467,389. However, we believe we are emerging as a
potential leader in the rapidly growing environmental and industrial separation
industries. The Company has developed and patented the Voraxial(R) Separator; a
proprietary technology that efficiently separates large volumes of
liquid/liquid, liquid/solids or liquid/liquid/solids with distinct specific
gravities. Management believes this superior separation quality is achieved in
real-time, and in much greater volumes, with a more compact, cost efficient and

energy efficient machine than any comparable product on the market today. The
Voraxial(R) Separator operates in-line and is scaleable.

The Company is presently researching and developing Voraxial(R)
solutions for various applications and markets including oil-water separation
and oil exploration and production.

THE OFFERING

This prospectus covers up to 9,543,363 shares of our common stock,
which may be sold by the selling shareholders identified in this prospectus. Of
these shares, 5,438,698 shares are underlying warrants exercisable at the
following prices:

265,250 shares are underlying warrants exercisable at $0.75 per share,
4,213,582 shares are underlying warrants exercisable at $1.00 per share,
516,666 shares are underlying warrants exercisable at $1.25 per share,
100,000 shares are underlying warrants exercisable at $3.00 per share,
100,000 shares are underlying warrants exercisable at $4.00 per share,
121,600 shares are underlying warrants exercisable at $6.00 per share, and
121,600 shares are underlying warrants exercisable at $9.00 per share.

The remaining 4,104,666 shares are underlying options exercisable at the
following prices:

2,000,000 shares are underlying options exercisable at $0.15 per share,
45,000 shares are underlying options exercisable at $0.30 per share,
697,333 shares are underlying options exercisable at $0.60 per share,
30,000 shares are underlying options exercisable at $0.71 per share,
200,000 shares are underlying options exercisable at $0.77 per share,
150,000 shares are underlying options exercisable at $0.80 per share,
225,000 shares are underlying options exercisable at $0.80 per share, and
757,333 shares are underlying options exercisable at $1.00 per share.

While we will not receive any proceeds from sales of shares of our common
stock by the selling shareholders, the Company will receive up to $11,166,883.80
from shares issued upon exercise of any warrants or options. The proceeds from
the exercise of warrants and options will be used for general working capital
purposes. The warrants and options expire on various dates between February 2007
and June 2009. In addition, the warrants are callable at a closing bid price of
$0.001 per underlying Common Share provided the Company's Common Stock trades at
or above $2.00 per share based for twenty consecutive trading days within 30
days of the Company's written notice of the Company's intention to call this
warrant. In the event this warrant has not been exercised by written notice
within 30 days of such notice, this warrant will cease to exist.

As of September 30, 2006, there are 21,492,235 shares of our common
stock outstanding. This number of outstanding shares excludes: 5,438,698 shares
of our common stock underlying warrants and 4,104,666 shares of common stock
underlying stock options issued to our employees and consultants.

SUMMARY FINANCIAL AND STATISTICAL DATA

The financial data set forth below under the captions "Results of
Operations Data" and "Balance Sheet Data" as of December 31, 2004 and for the
year ended December 31, 2005 are derived from our audited financial statements,
included elsewhere in this Prospectus, by Jewett, Schwartz & Associates & Co.,
LLP independent public accountants. The data for the nine months ended September
30, 2006 and September 30, 2005 is derived from our unaudited financial
statements included elsewhere in this prospectus. The results of operations for
the data for the nine months ended September 30, 2006 are not necessarily of
indicative of results to be expected for any other interim period or the entire
year. The financial data set forth below should be read in conjunction with the
financial statements and notes thereto included elsewhere in this Prospectus and
"Management's Discussion and Analysis of Financial Condition and Results of
Operations."

RESULTS OF OPERATIONS DATA

For the Year Ended Nine Months Ended
December 31, December 31, September 30,
2005 2004 2006 2005
---- ---- ---- ----

Net sales..................... $ 128,070 $ 19,000 $ 208,425 $128,000
Cost of sales................. $ 34,444 $ 0 $ 71,410 $ 34,000
Gross profit.................. $ 93,626 $ 19,000 $ 137,015 $ 94,000
Operating expenses............ $1,186,773 $1,748,000 $ 722,381 $947,000
Net loss...................... ($1,093,147) ($1,729,000) ($ 585,366) ($853,000)

Weighted average number of
common shares outstanding:
Basic & Diluted............ 18,257,808 16,899,376 20,067,888 18,291,356

Net loss per common share:
Basic & Diluted ($0.06) ($0.10) ($0.03) ($0.05)

BALANCE SHEET DATA

December 31, 2005 September 30, 2006
----------------- ------------------

Working capital (deficit).......................... ($ 5,882,005) ($6,467,389)
Total assets....................................... $ 218,063 $ 643,948
Total liabilities.................................. $ 424,703 $ 589,515
Shareholders' equity............................... ($ 206,640) ($ 54,433)

FORWARD LOOKING STATEMENTS

The discussion in this Prospectus regarding our business and operations
includes "forward-looking statements" which consist of any statement other than
a recitation of historical fact and can be identified by the use of
forward-looking terminology such as "may," "expect," "anticipate," "estimate" or
"continue" or the negative thereof or other variations thereon or comparable
terminology. The reader is cautioned that all forward-looking statements are
speculative, and there are certain risks and uncertainties that could cause
actual events or results to differ from those referred to in such
forward-looking statements. This disclosure highlights some of the important
risks regarding our business. The risks included should not be assumed to be the
only things that could affect future performance. Additional risks and
uncertainties include the potential loss of contractual relationships,
fluctuations in the volume of sales we make or transactions processed by our
customers, as well as uncertainty about the ability to collect the appropriate
amounts due to us.

RISK FACTORS

OUR INDEPENDENT AUDITORS HAVE RAISED SUBSTANTIAL DOUBT ABOUT OUR ABILITY TO
CONTINUE AS A GOING CONCERN.

Although we operated as a precision machine shop for a number of years,
we have only recently completed the development of the Voraxial Separator, and
we have not yet generated significant revenues from that product. As a result,
we have limited operating history in our planned business upon which you may
evaluate our business and prospects. The revenues and income potential of our
business and the markets of our separation technology are unproven. Our business
plan must be considered in light of risks, expenses, delays, problems, and
difficulties frequently encountered by development stage companies.

We have incurred operating losses since our inception, and we will
continue to incur net losses until we can produce sufficient revenues to cover
our costs. At December 31, 2005, we had an accumulated deficit of $5,882,005,
including a net loss of $1,091,005 for the year ended December 31, 2005. At
September 30, 2006, we have an accumulated deficit of $6,467,389 and net loss of
$585,366 for the nine months ended September 30, 2006. Even if we achieve
profitability, we may not be able to sustain or increase our profitability on a
quarterly or annual basis.

Our ability to generate future revenues will depend on a number of
factors, many of which are beyond our control. These factors include the rate of
market acceptance of our products, competitive efforts, and general economic
trends. Due to these factors, we cannot anticipate with any degree of certainty
what our revenues will be in future periods. You have limited historical
financial data and operating results with which to evaluate our business and our
prospects. As a result, you should consider our prospects in light of the early
stage of our business in a new and rapidly evolving market.

Our independent auditors have included in their audit report an
explanatory paragraph that states that our continuing losses from operations
raises substantial doubt about our ability to continue as a going concern.

WE HAVE BEEN LIMITED BY INSUFFICIENT CAPITAL, AND WE MAY CONTINUE TO BE SO
LIMITED.

In the past, we have lacked the required capital to market the Voraxial
Separator. Our inability to raise the funding or to otherwise finance our
capital needs could adversely affect our financial condition and our results of
operations, and could prevent us from implementing our business plan.

We may seek to raise capital through public and private equity
offerings, debt financing or collaboration, and strategic alliances. Such
financing may not be available when we need it or may not be available on terms
that are favorable to us. If we raise additional capital through the sale of our
equity securities, your ownership interest will be diluted and the terms of the
financing may adversely affect your holdings or rights as a stockholder.

OUR BUSINESS MODEL IS UNPROVEN AND IF IT IS NOT SUCCESSFULLY IMPLEMENTED, OUR
BUSINESS WILL FAIL.

Our business model is currently unproven and in the early stages of
development and we have not yet undertaken any substantial marketing activities.
The technological, marketing, and other aspects of our business will require
substantial resources and will undergo constant developmental change. Our
ability to develop a successful business model will be dependent upon the
relative success or failure of these respective aspects of our operations and
how effectively they work in concert with one another. If we expend significant
financial and management resources attempting to market the Voraxial Separator
to a specific industry segment, and we subsequently are unsuccessful in
generating sales from that segment, we may not have enough resources to market
to other industry segments. There are no assurances that we will successfully
develop our business model from the standpoint of successfully implementing an
efficient and effective marketing plan.

IF OUR PRODUCTS DO NOT ACHIEVE AND MAINTAIN MARKET ACCEPTANCE, OUR BUSINESS
WILL NOT BE SUCCESSFUL.

Even though we believe our product is successfully developed, our
success and growth will depend upon its acceptance by various potential users of
our product. Acceptance will be a function of our product being more cost
effective as compared to currently existing or future technologies. If our
product does not achieve market acceptance, our business will not be successful.
In addition, even if our product achieves market acceptance, we may not be able
to maintain that market acceptance over time if new products or technologies are
introduced that are more favorably received than our product or render our
products obsolete.

IF WE DO NOT DEVELOP SALES AND MARKETING CAPABILITIES OR ARRANGEMENTS
SUCCESSFULLY, WE WILL NOT BE ABLE TO COMMERCIALIZE OUR PRODUCT SUCCESSFULLY.

We have limited sales and marketing experience. We may market and sell
our product through a direct sales force or through other arrangements with
third parties, including co-promotion arrangements. Since we may market and sell
any product we successfully develop through a direct sales force, we will need
to hire and train qualified sales personnel.

OUR MARKET IS SUBJECT TO INTENSE COMPETITION. IF WE ARE UNABLE TO COMPETE
EFFECTIVELY, OUR PRODUCT MAY BE RENDERED NON-COMPETITIVE OR OBSOLETE.

We are engaged in a segment of the water filtration industry that is
highly competitive and rapidly changing. Many large companies, academic
institutions, governmental agencies, and other public and private research
organizations are pursuing the development of technology that can be used for
the same purposes as our product. We face, and expect to continue to face,
intense and increasing competition, as new products enter the market and
advanced technologies become available. We believe that a significant number of
products are currently under development and will become available in the future
that may address the water filtration segment of the market. If other products
are successfully developed, it may be marketed before our product.

Our competitors' products may be more effective, or more effectively
marketed and sold, than any of our products. Many of our competitors have:

o significantly greater financial, technical and human resources
than we have and may be better equipped to discover, develop,
manufacture and commercialize products; and

o more extensive experience in marketing water treatment products.

Competitive products may render our products obsolete or noncompetitive
before we can recover the expenses of developing and commercializing our
product. Furthermore, the development of new technologies and products could
render our product noncompetitive, obsolete, or uneconomical.

AS WE EVOLVE FROM A COMPANY PRIMARILY INVOLVED IN DESIGN AND DEVELOPMENT TO ONE
ALSO INVOLVED IN COMMERCIALIZATION, WE MAY ENCOUNTER DIFFICULTIES IN MANAGING
OUR GROWTH AND EXPANDING OUR OPERATIONS SUCCESSFULLY.

We may experience a period of rapid and substantial growth that may
place a strain on our administrative and operational infrastructure, and we
anticipate that continued growth could have a similar impact. As our product
continues to enter and advance in the market, we will need to expand our
development, regulatory, manufacturing, marketing and sales capabilities or
contract with third parties to provide these capabilities for us. As our
operations expand, we expect that we will need to manage additional
relationships with various collaborative partners, suppliers, and other third
parties.

IF WE ARE UNABLE TO ADEQUATELY PROTECT OUR TECHNOLOGY, OR IF WE INFRINGE THE
RIGHTS OF OTHERS, WE MAY NOT BE ABLE TO DEFEND OUR MARKETS OR TO SELL OUR
PRODUCT.

Our success may depend in part on our ability to continue and expand
our patent protection both in the United States and in other countries for our
product. Due to evolving legal standards relating to the patentability,
validity, and enforceability of patents covering our product and the scope of
claims made under these patents, our ability to obtain and enforce patents is
uncertain and involves complex legal and factual questions. Accordingly, rights
under any issued patents may not provide us with sufficient protection for our

product or provide sufficient protection to afford us a commercial advantage
against competitive products or processes.

Our success may also depend in part on our ability to operate without
infringing the proprietary rights of third parties. The manufacture, use, or
sale of our product may infringe on the patent rights of others. Likewise, third
parties may challenge or infringe upon our existing or future patents.
Proceedings involving our patents or patent applications or those of others
could result in adverse decisions regarding:

o the patentability of our inventions relating to our product;
and/or

o the enforceability, validity, or scope of protection offered by
our patents relating to our product.

Litigation may be necessary to enforce the patents we own and have
applied for (if they are awarded), copyrights, or other intellectual property
rights, to protect our trade secrets, to determine the validity and scope of the
proprietary rights of others, or to defend against claims of infringement. This
type of litigation could result in the expenditure of significant financial and
managerial resources and could result in injunctions preventing us from
distributing certain products. Such claims could materially adversely affect our
business, financial condition, and results of operations.

WE ARE DEPENDENT ON KEY PERSONNEL AND THE LOSS OF THE SERVICES OF ANY SUCH
PERSONNEL COULD HAVE A MATERIAL ADVERSE EFFECT ON US.

We are dependent upon the availability and the continued performance of
the services of Alberto DiBella and John DiBella. The loss of the services of
any such personnel could have a material adverse effect on us. In addition, the
availability of skilled personnel is extremely important to our growth strategy
and our failure to attract and retain such personnel could have a material,
adverse effect on us. We do not currently maintain any key man life insurance
covering these persons.

OUR OPERATIONS ARE SUBJECT TO GOVERNMENTAL APPROVALS AND REGULATIONS AND
ENVIRONMENTAL COMPLIANCE, WHICH MAY SUBJECT US TO INCREASING OPERATIONAL COSTS.

Our operations are subject to extensive and frequently changing
federal, state, and local laws and substantial regulation by government
agencies, including the United States Environmental Protection Agency (EPA), the
United States Occupational Safety and Health administration (OSHA) and the
Federal Aviation Administration (FAA). Among other matters, these agencies
regulate the operation, handling, transportation and disposal of hazardous
materials used by us during the normal course of our operations, govern the
health and safety of our employees and certain standards and licensing
requirements for our aerospace components that we contract manufacture. We are
subject to significant compliance burden from this extensive regulatory
framework, which may substantially increase our operational costs.

We believe that we have been and are in compliance with environmental
requirements and believe that we have no liabilities under environmental
requirements. Further, we have not spent any funds specifically on compliance

with environmental laws. However, some risk of environmental liability is
inherent in the nature of our business, and we might incur substantial costs to
meet current or more stringent compliance, cleanup, or other obligations
pursuant to environmental requirements in the future. This could result in a
material adverse effect to our results of operations and financial condition.

OUR BUSINESS HAS A SUBSTANTIAL RISK OF PRODUCT LIABILITY CLAIMS. IF WE ARE
UNABLE TO OBTAIN APPROPRIATE LEVELS OF INSURANCE, A PRODUCT LIABILITY CLAIM
AGAINST US COULD AVERSELY AFFECT OUR BUSINESS.

Our business exposes us to possible claims of personal injury, death,
or property damage, which may result from the failure, or malfunction of any
component or subassembly manufactured or assembled by us. While we have product
liability insurance, any product liability claim made against us may have a
material adverse effect on our business, financial condition, or results of
operations in light of our poor financial condition, losses and limited
revenues.

OUR SHARES OF COMMON STOCK HAVE TRADED ON A LIMITED BASIS AND YOU MAY FIND IT
DIFFICULT TO DISPOSE OF YOUR SHARES OF OUR STOCK, WHICH COULD CAUSE YOU TO LOSE
ALL OR A PORTION OF YOUR INVESTMENT IN OUR COMPANY.

Our shares of common stock are currently quoted on the OTC Bulletin
Board. The trading in shares of our common stock has been limited and we
anticipate the trading market in the foreseeable future will continue to be
limited. As a result, you may find it difficult to dispose of shares of our
common stock and you may suffer a loss of all or a substantial portion of your
investment in our common stock.

OUR COMMON STOCK IS COVERED BY SEC "PENNY STOCK" RULES WHICH MAY MAKE IT MORE
DIFFICULT FOR YOU TO SELL OR DISPOSE OF OUR COMMON STOCK, WHICH COULD CAUSE YOU
TO LOSE ALL OR A PORTION OF YOUR INVESTMENT IN OUR COMPANY.

Our common stock is covered by an SEC rule that imposes additional
sales practice requirements on broker-dealers who sell such securities to
persons other than established customers and accredited investors, which are
generally institutions with assets in excess of $5,000,000, or individuals with
net worth in excess of $1,000,000 or annual income exceeding $200,000 or
$300,000 jointly with their spouse. For transactions covered by the rule, the
broker-dealer must make a special suitability determination for the purchaser
and transaction prior to the sale. Consequently, the rule may affect the ability
of broker-dealers to sell our securities, and also may affect the ability of
purchasers of our stock to sell their shares in the secondary market. It may
also diminish the number of broker-dealers that may be willing to make a market
in our common stock, and it may affect the level of news coverage we receive.

FUTURE SALES BY OUR STOCKHOLDERS MAY NEGATIVELY AFFECT OUR STOCK PRICE AND OUR
ABILITY TO RAISE FUNDS IN NEW STOCK OFFERINGS.

Sales of our common stock in the public market following this offering
could lower the market price of our common stock due to the additional shares in
the market. Sales may also make it more difficult for us to sell equity
securities or equity-related securities in the future at a time and price that
our management deems acceptable or at all.

THE EXERCISE OF THE WARRANTS AND OPTIONS COULD NEGATIVELY AFFECT THE MARKET
PRICE FOR OUR COMMON STOCK.

To the extent that holders of the options or warrants exercise such
convertible securities and then sell the underlying shares of common stock in
the open market, our common stock price may decrease due to the additional
shares in the market.
8

CAPITALIZATION

The following tables set forth our capitalization as of September 30,
2006. The tables should be read in conjunction with our consolidated financial
statements and related notes included elsewhere in this prospectus.

September 30, 2006
------------------

Current maturities of long-term debt............................................................. $ 0
Long-term debt................................................................................... 0
Current Liabilities ............................................................................. 589,515
Shareholders' equity:
Preferred Stock; 7,250,000 authorized;
Shares authorized, 0 Shares issued and outstanding.......................................... 0
Common stock; $0.001 par value; 42,750,000
Shares authorized; 21,492,235 shares issued and outstanding................................. 21,492
Additional paid-in capital.................................................................... 6,520,330
Accumulated deficit........................................................................... (6,467,389)
Total shareholders' deficiency................................................................... $ (54,433)
=============
Total liabilities and shareholders deficiency.................................................... $ 643,948
=============

PRICE RANGE OF COMMON STOCK AND DIVIDEND POLICY

Our common stock is quoted on the NASDAQ Over-The-Counter Bulletin
Board ("OTCBB") under the symbol EVTN. The bid quotations below, as provided by
Interactive Data, have been reported for the period ending March 31, 2004
through the period ending September 30, 2006. There is no assurance that an
active trading market will develop which will provide liquidity for our existing
shareholders or for persons who may acquire common stock through the exercise of
warrants and options. On January 30, 2007, the closing price for our common
stock was $0.45. The quotations reflect inter-dealer prices, without retail
mark-up, markdown or commission, and may not represent actual transactions.

BID QUOTATIONS

Quarter Ended High Low
------------- ---- ---

March 31, 2004 $1.21 $0.80
June 30, 2004 $1.23 $0.79
September 30, 2004 $1.15 $0.65
December 31, 2004 $0.99 $0.60

March 31, 2005 $0.85 $0.42
June 30, 2005 $0.60 $0.38
September 30, 2005 $0.85 $0.41
December 31, 2005 $0.70 $0.45

March 31, 2006 $0.70 $0.50
June 30, 2006 $0.79 $0.48
September 30, 2006 $0.60 $0.46

HOLDERS

As of December 15, 2006, there were over 775 holders of record of our
common stock outstanding. Our transfer agent is Jersey Transfer & Trust Company,
Inc., Post Office Box 36, Verona, New Jersey 07044.

No prediction can be made as to the effect, if any, that future sales
of shares of common stock or the availability of common stock for future sale
will have on the market price of the common stock prevailing from time-to-time.
Sales of substantial amounts of common stock on the public market could
adversely affect the prevailing market price of the common stock.

DIVIDENDS

We have not paid a cash dividend on the common stock since our
acquisition of FPA. The payment of dividends may be made at the discretion of
our board of directors and will depend upon, among other things, our operations,
our capital requirements and our overall financial condition. As of the date of
this prospectus, we have no intention to declare dividends.

A SPECIAL NOTE ABOUT PENNY STOCK RULES

Our common stock is covered by an SEC rule that imposes additional
sales practice requirements on broker-dealers who sell such securities to
persons other than established customers and accredited investors, which are
generally institutions with assets in excess of $5,000,000, or individuals with
net worth in excess of $1,000,000 or annual income exceeding $200,000 or
$300,000 jointly with their spouse. For transactions covered by the rule, the
broker-dealer must make a special suitability determination for the purchaser
and transaction prior to the sale. Consequently, the rule may affect the ability
of broker-dealers to sell our securities, and also may affect the ability of
purchasers of our stock to sell their shares in the secondary market. It may
also cause less broker- dealers to be willing to make a market in our common
stock, and it may affect the level of news coverage we receive.

USE OF PROCEEDS

We will not receive any proceeds from the sale of our common stock by
the selling shareholders. However, we may receive up to $11,166,883.80 of
proceeds from the options and warrants exercisable to acquire the shares of
common stock we are registering under this prospectus. Any proceeds from the
exercise of options and warrants will be used for working capital.

MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL
CONDITION AND PLAN OF OPERATIONS

GENERAL

Management's discussion and analysis contains various forward-looking
statements. These statements consist of any statement other than a recitation of
historical fact and can be identified by the use of forward-looking terminology
such as "may," "expect," "anticipate," "estimate" or "continue" or use of
negative or other variations or comparable terminology.

We caution that these statements are further qualified by important
factors that could cause actual results to differ materially from those
contained in the forward-looking statements, that these forward-looking
statements are necessarily speculative, and there are certain risks and
uncertainties that could cause actual events or results to differ materially
from those referred to in such forward-looking statements.

OVERVIEW

The Company has developed and patented the Voraxial(R) Separator; a
proprietary technology that efficiently separates large volumes of
liquid/liquid, liquid/solids or liquid/liquid/solids with distinct specific
gravities. We have had limited sales and have shipped units of the Voraxial(R)
Separator on a trial and rental basis to a number of different companies that
include a wide range of industrial applications, including produced water
applications for the oil industry (both offshore oil rigs and onland production
facilities), liquid/liquid and liquid/solid applications for the food processing
industry and the uranium industry. We have installed several Voraxial(R)
Separators to date including units to the Alaska Department of Environmental
Conservation, the US Navy and to a leading uranium producing company in Canada
for oil/water separation. During 2006, we sold a Voraxial(R) 4000 Separator to
ConocoPhillips for produced water separation. The Company is presently marketing
the developing Voraxial(R) Separator as a potential solution for various
applications and markets including oil-water separation and oil exploration and
production,.

YEAR ENDED DECEMBER 31, 2005 COMPARED TO YEAR ENDED DECEMBER 31, 2004

REVENUE

We continued to focus our efforts and resources to the manufacturing,
assembling, marketing and selling of the Voraxial(R) Separator. Revenues
increased 572% to $128,070 for year ended December 31, 2005 as compared to
$19,220 for the year ended December 31, 2004. The increase is a result of a sale
of the Voraxial Separator and in-house testing and rental shipments to customers
interested in utilizing the Voraxial Separator. Management believes the interest
for the Voraxial Separator for liquid/liquid, liquid/solid and
liquid/liquid/solid separation is increasing from a variety of industries. We
believe we have increased the exposure and awareness of the Voraxial Separator
through our marketing programs and expect to increase revenues from the sale and
lease of the Voraxial Separator in 2007.

COSTS AND EXPENSES

Costs and expenses decreased by 32% or $561,257 to $1,186,743 for the
year ended December 31, 2005 as compared to $1,748,000 for the year ended
December 31, 2004. The decrease is due to a consolidation of activities
resulting in decreases in general and administrative expenses and increases in
research and development during the year ended December 31, 2005. Increase in
research and development was primarily due to produced water trials.

GENERAL AND ADMINISTRATIVE EXPENSES

General and Administrative expenses decreased by 59% or $655,001 to
$455,999 for the year ended December 31, 2005 from $1,111,000 for the year ended
December 31, 2004. The decrease is principally due to a non-cash equity
transaction in 2004 for services. The expense is related to the marketing of the
Voraxial(R) Separator.

RESEARCH AND DEVELOPMENT EXPENSES

Research and Development expenses increased 15% to $730,774 for the
year ended December 31, 2005 from $637,000 for the year ended December 31, 2004.
This increase was due to our continuing efforts to enter into the produced water
segment of the oil industry.

NINE MONTHS ENDED SEPTEMBER 30, 2006 COMPARED TO NINE MONTHS ENDED SEPTEMBER 30,
2005.

REVENUE

Our revenues increased 62% to $208,425 for the nine months ended
September 30, 2006 as compared to $128,000 for the nine months ended September
30, 2005. The increase in revenue was due to the sales of Voraxial(R) Separator
equipment. The Company continues to focus on its sales and marketing program for
the Voraxial(R) Separator, specifically in the oil exploration and production
market. Interest in the Voraxial Separator has increased significantly in the
past several quarters, as such, Management believes such efforts will continue
to result in additional clients and increasing revenues in 2006.

COSTS AND EXPENSES

Costs and expenses decreased by 24% or $224,619 to $722,381 for the
nine months ended September 30, 2006 as compared to $947,000 for the nine months
ended September 30, 2005. The decrease is due to a consolidation of activities
resulting in a decrease in research and development during the nine months ended
September 30, 2006. This was partially offset by an increase in general and
administrative expenses, which includes, but not limited to sales and marketing
in the oil exploration and production industry

RESEARCH AND DEVELOPMENT EXPENSES

Research and Development expenses decreased by 52% to $281,124 for the
nine months ended September 30, 2006, as compared to $588,000 for the previous

nine months ended September 30, 2005. The Company has finalized the development
of the Voraxial(R) Separator and has begun the sales and marketing of the
product. However, we continue to seek improvements to the product, specifically
within the oil industry.

GENERAL AND ADMINISTRATIVE EXPENSES

General and Administrative expenses increased by 22% to $441,257 for
the nine months ended September 30, 2006 up from $359,000 for the nine months
ended September 30, 2005. The increase was due to various overhead expenses,
including, but not limited to sales and marketing in the oil exploration and
production industry. We continue to focus our efforts on marketing of the
Voraxial(R) Separator.

LIQUIDITY AND CAPITAL RESOURCES

Cash at September 30, 2006 was $381,492. Working capital surplus at
September 30, 2006 was $39,536 as compared to a working capital deficit at
December 31, 2005 of $221,978. The increase in the working capital was primarily
due to a $304,801 increase in cash, an increase in inventory of $71,098, an
increase in Accounts Receivable of $41,430 and increase in prepaid expenses of
$8,997. These amounts were partially offset by an increase in Accounts Payable
and Accrued Expenses of $163,812.

At September 30, 2006 the Company had an accumulated deficit of
$6,467,389. We anticipate generating positive cash flow from the Voraxial(R)
Separator by the end of 2007. To the extent such revenues and corresponding cash
flows do not materialize, we will continue to require infusion of capital to
sustain our operations. We cannot be assured that we will generate revenues or
that the level of any future revenues will be self-sustaining. Furthermore, we
cannot provide any assurances that required capital will be obtained or that
terms of such required capital may be acceptable to us.

The Company has funded working capital requirements and intends to fund
current working capital requirements through third party financing, including
the private placement of securities. However, the Company cannot provide any
assurances that it will be able to obtain adequate financing. If the Company is
unable to obtain adequate financing, it may reduce its operating activities
until sufficient funding is secured or revenues are generated to support
operating activities. During the three months ended September 30, 2006, the
Company received $445,000 from four accredited investors that purchased an
aggregate of 1,112,500 shares of the Company's restricted common stock at $0.40
per share. During the nine months ending September 30, 2006, the Company
received $893,000 from 19 accredited investors that purchased an aggregate of
2,232,500 shares of the Company's restricted common stock at $0.40 per share.

The Company has expanded its sales and marketing efforts for produced
water separation in the oil exploration and production market. During the nine
months ended September 30, 2006 the Company sold and delivered a Voraxial 4000
Separator for produced water separation to ConocoPhillips. ConocoPhillips is
among the largest five integrated energy companies and refiners in the United
States. The machine will be used to enhance the handling of large volumes of
produced water and water injection at a production facility. The Company also
received a purchase order to provide Transocean Inc. semi submersible rig Sedco

702 with a Voraxial 2000 Offshore Deck Water Drainage System. The system will be
utilized to handle and separate contaminated drill floor run-off water
containing solids and drilling fluids on their offshore rig.

CONTINUING LOSSES

We may be unable to continue as a going concern, given our limited
operations and revenues and our significant losses to date. Consequently, our
working capital may not be sufficient and our operating costs may exceed those
experienced in our prior years. In light of these recent developments, we may be
unable to continue as a going concern.

The Company has experienced net losses, has a working capital deficit
and sustained cash outflows from operating activities and had to raise capital
to sustain operations. There is no assurance that the Company's developmental
and marketing efforts will be successful, that the Company will ever have
commercially accepted products, or that the Company will achieve significant
revenues. If the Company is unable to successfully commercialize its Voraxial
Separator, it is unlikely that the Company could continue its business. The
Company will continue to require the infusion of capital until operations become
profitable. During 2007, the Company anticipates seeking additional capital,
increasing sales of the Voraxial Separator and continuing to restrict expenses.
However, substantial doubt exists about the ability of the Company to continue
as a going concern.

RECENT ACCOUNTING PRONOUNCEMENTS

In June 2002, the FASB issued SFAS No. 146, "Accounting for Costs
Associated with Exit or Disposal Activities." The Company's adoption of SFAS No.
146 on January 1, 2003 did not have any material effect on the financial
statements of the Company.

In December 2003, the FASB issued Interpretation No. 46R,
"Consolidation of Variable Interest Entities" in an effort to expand upon and
strengthen existing accounting guidance that addresses when a company should
include in its financial statements the assets, liabilities and activities of
variable interest entities, including special-purpose entities or off-balance
sheet structures. The consolidation requirements of FIN No. 46R have a variety
of implementation dates. The Company believes the impact of FIN No. 46R on its
financial position and results of operations will not be material, but the
Company will continue to evaluate the impact of FIN No. 46R during the first
quarter of 2004.

In May 2003, the FASB issued SFAS No. 150, "Accounting for Certain
Financial Instruments with Characteristics of both Liabilities and Equity." This
statement affects the issuer's accounting for three types of freestanding
financial statements: mandatorily redeemable shares, put and forward purchase
contracts that require the issuer to buy back some of its shares in exchange for
cash or other assets, and certain obligations that can be settled in shares.
This statement is effective for all financial instruments entered into or
modified after May 31, 2003, and otherwise effective at the beginning of the
first interim period beginning after June 15, 2003. The impact of adopting FASB
No. 150 was not material to the Company's financial position and results of
operations.

In December 2003, the Securities and Exchange Commission (SEC),
published Staff Accounting Bulletin (SAB) No. 104, "Revenue Recognition." This
SAB updates portions of the Securities and Exchange Commission (SEC) staff's
interpretive guidance provided in SAB 101 and included in Topic 13 of the
Codification of Staff Accounting Bulletins. SAB 104 deletes interpretative
material no longer necessary, and conforms the interpretive material retained,
because of pronouncements issued by the FASB's Emerging Issues Task Force (EITF)
on various revenue recognition topics, including EITF 00-21, "Revenue
Arrangements with Multiple Deliverables." SAB No. 104 also incorporates into the
SAB Codification certain sections of the SEC staff's "Revenue Recognition in
Financial Statements - Frequently Asked Questions and Answers." SAB No. 104 does
not have a material impact on the Company's financial position and results of
operations since the Company's revenue recognition practices previously
conformed to the interpretations codified by SAB No. 104.

Management does not expect these statements to have a material impact
on the consolidated financial statements.

BUSINESS

OUR HISTORY

Enviro Voraxial Technology, Inc. was incorporated in Idaho on October
19, 1964, under the name Idaho Silver, Inc. From our inception through 1994, we
were engaged in acquiring mining claims and exploring for silver and lead in
Idaho. In May of 1996, we entered into an agreement and plan of reorganization
with a privately held Florida corporation, Florida Precision Aerospace, Inc.
("FPA"), and its shareholders. FPA was incorporated on February 26, 1993. We
exchanged 10,000,000 newly issued post-split shares of our common stock, or
approximately 97% of our shares then issued and outstanding for all of the
issued and outstanding shares of FPA. As a result of this reorganization, the
shareholders of FPA gained control of our company and FPA became our wholly
owned subsidiary. Because FPA's management was more qualified to focus our
business on that of FPA, our officers and directors resigned and were replaced
by FPA's designees. At the close of the transaction, we changed our name to
Enviro Voraxial Technology, Inc.

GENERAL

We believe we are emerging as a potential leader in the rapidly growing
environmental and industrial separation industries. The Company has developed
and patented the Voraxial(R) Separator; a proprietary technology that
efficiently separates large volumes of liquid/liquid, liquid/solids or
liquid/liquid/solids with distinct specific gravities. Management believes its
high separation quality is achieved in real-time, and in much greater volumes,
with a more compact, cost efficient and energy efficient machine than any
comparable product on the market today. The Voraxial(R) Separator operates
in-line and is scaleable.

The size and efficiency advantages provided by the Voraxial(R)
Separator to the end-user have provided us with a variety of market
opportunities. We have generated limited revenues to date partially because of
insufficient funds to adequately market our product; however, we have received
inquiries from parties in various industries, including oil exploration and
production.

We have had limited sales and have shipped units of the Voraxial(R)
Separator on a trial and rental basis to a number of different companies that
include a wide range of industrial applications, including produced water
applications for the oil industry (both offshore oil rigs and onland production
facilities), liquid/liquid and liquid/solid applications for the food processing
industry and the uranium industry. We have installed several Voraxial(R)
Separators to date including units to the Alaska Department of Environmental
Conservation, the US Navy and to a leading uranium producing company in Canada
for oil/water separation. During 2006, we sold a Voraxial(R) 4000 Separator to
ConocoPhillips for produced water separation.

VORAXIAL(R) SEPARATOR

heavier compounds to gravitate to the outside of the flow and the lighter
elements to move to the center where an inner core is formed. The liquid stream
processed by the machine is divided into separate streams of heavier and lighter
liquids and solids. As a result of this process, separation is achieved.

The Voraxial(R) Separator is a self-contained, non-clogging device that
can be powered by an electric motor, diesel engine or by hydraulic power
generation. Further, the Voraxial(R) Separator's scalability allows it to be
utilized in a variety of industries and to process various amounts of liquid.
The following are the various sizes and the corresponding capacity range:

PRODUCT AND CAPACITY RANGE

Model Diameter Capacity Range
Number Size Gallons Per Minute
------ ---------- ------------------
Voraxial(R)1000 1 inch 3 - 5
Voraxial(R)2000 2 inches 25 - 80
Voraxial(R)4000 4 inches 250 - 600
Voraxial(R)8000 8 inches 2,000 - 6,000

We currently maintain an inventory of various models of the Voraxial(R)
Separator. During fiscal year 2006, we further tested, demonstrated and
delivered on a trial and rental basis the Voraxial(R) Separator units to
companies within various industries including energy production, wastewater,
manufacturing and mining. During 2006 the Company provided Voraxial(R)
Separators to several firms and is engaged in discussions to deliver additional
Voraxial(R) Separators on an income-producing basis.

Management believes that our Voraxial(R) Separator offers substantial
applications on a cost-effective basis, including: oil exploration & production,
oil remediation services, municipal wastewater treatment, bilge water
purification, food processing waste treatment and numerous other industrial
production and environmental remediation processes. We also believe that the
quality of the water separated from the contaminant is good enough to recycle
back into the process stream (back into the plant) or discharge to the
environment. As clean water becomes less available to the ever-increasing world
population, this technology may become more valuable.

VORAXIAL(R) SEPARATOR MARKET

The need for effective and cost efficient wastewater treatment and
separation technology is global in scale. Moreover, virtually every industry
requires some type of separation process either during the manufacturing
process, prior to treatment or discharge of wastewater into the environment, for
general clean up, or emergency response capability. Separation processes,
however, are largely unknown to the average consumer. These processes are deeply
integrated in almost all industrial processes from oil to wastewater to
manufacturing. Management believes that the Voraxial(R) technology has
applications in most, if not all major separation industries. The unique
characteristics of the Voraxial(R) allow it to be utilized either as a
stand-alone unit or within an existing system to provide a more efficient and
cost effective way to handle the separation needs of the customer.

We believe that we are the only front-end solution for the separation
industry that can offer increased productivity while reducing the physical space
and energy required to operate the unit. These advantages translate into the
potential for substantial operating cost efficiencies that may increase the
profitability of the solution's end user.

If environmental regulations, both domestically and internationally,
become more stringent, companies may be required to more effectively treat their
wastewater prior to discharge. We believe this offers a good opportunity for the
Company as the Voraxial(R) Separator can be utilized in most separation
applications to significantly increase the efficiency of the separation
processes while simultaneously reduce the cost to the end-user.

Management believes that the oil industry, and more specifically the
produced water market within this industry, represents a good opportunity for
significant sales growth for the Voraxial Separator. The produced water market
is worldwide and the need for effective produced water (oil/water) separation is
a major issue for both offshore and land-based oil production facilities. The
ability to efficiently separate produced water waste streams (oil and water) has
enormous economical and environmental consequences for the oil production
industry. Produced water comprises over 98% of the total waste volume generated
by the oil and gas industry, making it the largest volume waste stream
associated with oil and gas production.

Oil reservoirs frequently contain large volumes of water and as oil
wells mature (the oil field becomes depleted), the amount of produced water
increases. According to American Petroleum Institute (API), about 18 billion
barrels of produced water was generated by US onshore operations in 1995.
Worldwide, the total amount of produced water generated in 1999, according to
Khatib and Verbeek, was approximately 77 billion barrels. Produced water volumes
will continue to increase as oil wells mature.

We believe that the necessity to process and efficiently separate high
volumes of liquids coupled with the more stringent environmental regulations
worldwide will continue to increase the demand for the Voraxial(R) Separator.
The Voraxial(R) provides efficient separation while decreasing the amount of
space, energy and weight to conduct the separation. In addition to oil
separation, the Voraxial can also perform solid (sand and grit) extraction,
which prevents production damage by increasing the life of the well.

INVENTORY

Other than our Voraxial(R) Separators, we maintain no inventory of
finished parts until we receive a customer order. We currently have various
models of the Voraxial(R) Separator in inventory, which includes certain models
located at third party facilities on a trial basis.

COMPETITION

We are subject to competition from a number of companies who have
greater experience, research abilities, engineering capability and financial
resources than we have. Although we believe our Voraxial(R) Separator offers
applications which accomplish better or similar results on a more cost-effective
basis than existing products, other products have, in some instances, attained
greater market and regulatory acceptance. These competitors include, but are not
limited to Westfalia and AlfaLaval.

MARKETING

The Company's products and services are marketed through our existing
staff and consultants. We have presented the Voraxial(R) Separator at several
prominent trade shows in the past fiscal year. In February 2005, we demonstrated
our Voraxial(R) Separator in Shell Technology Ventures (STV) trade booth, a
division of Royal Dutch/Shell Group (NYSE:RD), at the 22nd SPE/IADC Drilling
Conference and Exhibition in Amsterdam, The Netherlands. Our objective in
attending the conference was to increase awareness and strengthen relationships
between STV and members of the SPE/IADC while providing us with the exposure
and, hence, the business opportunities with potential customers. The specific
applications addressed with our separation technology at the SPE/IADC Drilling
Conference were the treatment of produced water and the separation of oil and
water at the various steps in the oil production process; namely, extraction,
transportation and initial refining of crude oil.

The Company believes it has received a great response from potential
clients and manufacturers representatives from the above-mentioned tradeshows
and is still pursuing some of these opportunities. We anticipate presenting the
Voraxial(R) Separator at additional tradeshows in 2007.

SOURCES AND AVAILABILITY OF RAW MATERIALS

The Voraxial(R) Separator is currently manufactured and assembled at
our Fort Lauderdale, Florida facilities.

The materials needed to manufacture our Voraxial(R) Separator have been
provided by Baldor Electric Co., Hughes Supply Inc. and SKF USA Inc., among
other suppliers. We have no written agreements with suppliers. We do not
anticipate any shortage of component parts.

INTELLECTUAL PROPERTY

We currently hold several patents pertaining to the Voraxial(R)
Separator and are continually working on developing other patents. The Company
owns United States Patent #6,248,231, #5,904,840 and #5,084,189. The latest
patent, Patent #6,248,231 was registered in 2001 for Apparatus with Voraxial(R)
Separator and Analyzer. Patent #5,904,840 is for Apparatus for Accurate
Centrifugal Separation of Miscible and Immiscible Media, which is for technology
invented by our president and sole director, Alberto DiBella, and registered in
1999. The other is for the Method and Apparatus for Separating Fluids having
Different Specific Gravities. This is for technology invented by Harvey Richter
and registered in 1992 to Richter Systems, Inc. In 1996, we acquired assets,
including this patent from Richter Systems, Inc. The method and apparatus for
each of these is applied in our Voraxial(R) Separator. The Company has filed for
additional patents pertaining to the Voraxial(R) Separator. These patents are
still pending.

In addition, on December 16, 2003, we received trademark protection for
the word "Voraxial".

PRODUCT LIABILITY

Our business exposes us to possible claims of personal injury, death or
property damage, which may result from the failure, or malfunction of any
component or subassembly manufactured or assembled by us. We have product
liability insurance up to $1,000,000 per incident. However, any product
liability claim made against us may have a material adverse effect on our
business, financial condition or results of operations in light of our poor
financial condition, losses and limited revenues.

We obtained directors and officers, and general insurance coverage in
2004. We obtained product liability insurance in 2005.

RESEARCH AND DEVELOPMENT

In our past two fiscal years, we have spent approximately $1,246,000 on
product research and development. The Company has finalized the development of
the Voraxial(R) Separator. Although we will continually work on advancing the
technology and applications whereby the technology can be used, we do not
anticipate devoting a significant portion of any future funds to this area of
the business.

EMPLOYEES

We have 4 employees. All of our employees work full-time. None of our
employees are members of a union. We believe that our relationship with our
employees is favorable. We intend to add additional employees in the upcoming
year, including managers, sales representatives and engineers.

PROPERTIES

During September 2004, the Company entered into a three (3) year lease
for an office and manufacturing facility located at 821 NW 57th Place, Fort
Lauderdale, FL 33309. The lease is approximately $5,640 per month for the
initial two years of the lease and approximately $5,700 per month for the third
year of the lease. The Company has the option to renew the lease at the end of
the three-year term. We believe this facility is adequate to maintain our
operations for the next 24 months.

MANAGEMENT

Directors and executive officers

The following sets forth the names and ages of our officers and
directors. Our directors are elected annually by our shareholders, and the
officers are appointed annually by our board of directors.

Name Age Position
---- --- --------

Alberto DiBella 73 President and Director
John A. DiBella 34 Executive Vice President of
Business Development

ALBERTO DIBELLA is a graduate of the Florence Technical Institute,
Italy, where he obtained a degree in mechanical engineering in 1952. After
immigrating to the United States in 1962, Mr. DiBella worked in New Jersey for a
major tool manufacturer. From 1988 to 1993, he was the President of E.T.P., Inc,
a machining business, where he was responsible for day-to-day operations of the
company. In 1993, he relocated to Florida and founded FPA, our wholly owned
subsidiary. Since our inception he has worked in the day-to-day operations of
FPA. He has been our president and chairman since June 1996 and president and
chairman of our subsidiary, FPA, since its organization in February 1993.

JOHN A. DIBELLA has served as an employee of our Company since January
2002. From 2000 through January 2002 Mr. DiBella provided consulting services to
our Company. Mr. DiBella currently serves as the Company's Vice President of
Business Development. Mr. DiBella co-founded and served as President of PBCM, a
financial management company located in New Jersey from 1997 to 1999. While at
PBCM, Mr. DiBella was involved in various consulting services regarding the
development of publicly traded companies, including establishing a management
team, negotiating partnerships, licensing agreements and investigating merger
and acquisition opportunities. Prior to co-founding PBCM, Mr. DiBella served as
a Securities Analyst in the Equities and Derivatives Department for Donaldson,
Lufkin and Jenrette, a NYSE member firm. Mr. DiBella holds a Bachelor of Science
Degree in Finance and Economics from Rutgers University. Mr. DiBella is the
nephew of Alberto DiBella.

COMMITTEES

To date, we have not established an audit committee. Due to our
financial position, we have been unable to attract qualified independent
directors to serve on our board. Our board of directors, solely consisting of
Alberto DiBella, reviews the professional services provided by our independent
auditors, the independence of our auditors from our management, our annual
financial statements and our system of internal accounting controls. Mr. DiBella
is not considered a "financial expert."

We have not established a compensation committee or nominating
committee.

ADVISORY COMMITTEE

We have established an Advisory Committee. The purpose of the Advisory
Committee is to provide business advice and recommendations to management of the
Company. The Advisory Committee consists of J. John Combs, Barry Gafner, Kevin
Mulshine and Henry Schlesinger. These individuals serve for a 2-year term.

On February 18, 2004, we issued options to purchase an aggregate of
30,000 shares of our common stock exercisable at $0.71 per share to three of the
individuals as consideration for joining our advisory committee. The options are
exercisable until February 18, 2007.

INDEMNIFICATION

The Idaho Statutes permit the indemnification of directors, employees,
officers and agents of Idaho corporations. Our Articles of Incorporation and
Bylaws provide that we shall indemnify its directors and officers to the fullest
extent permitted by the Idaho Statutes.

The provisions of the Idaho Statutes that authorize indemnification do
not eliminate the duty of care of a director, and in appropriate circumstances
equitable remedies such as injunctive or other forms of non-monetary relief will
remain available under Idaho. In addition, each director will continue to be
subject to liability for (a) violations of criminal laws, unless the director
had reasonable cause to believe his conduct was lawful or had no reasonable
cause to believe his conduct was unlawful, (b) deriving an improper personal
benefit from a transaction, (c) voting for or assenting to an unlawful
distribution and (d) willful misconduct or conscious disregard for our best
interests in a proceeding by or in the right of a shareholder. The statute does
not affect a director's responsibilities under any other law, such as the Idaho
securities laws.

The effect of the foregoing is to require us to indemnify our officers
and directors for any claim arising against such persons in their official
capacities if such person acted in good faith and in a manner that he reasonably
believed to be in or not opposed to the best interests of the corporation and,
with respect to any criminal action or proceeding, had no reasonable cause to
believe his conduct was unlawful.

Insofar as indemnification for liabilities arising under the Securities
Act of 1933 may be permitted to our directors, officers or persons in control
pursuant to the foregoing provisions, we have been informed that in the opinion
of the Securities and Exchange Commission, such indemnification is against
public policy as expressed in the act and is therefore unenforceable.

EXECUTIVE COMPENSATION

The table below sets forth compensation for the past three years
awarded to, earned by or paid to our chief executive officer and each executive
officer whose compensation exceeded $100,000 for the year ended December 31,
2005.

SUMMARY COMPENSATION TABLE

Long Term Compensation
Annual Compensation Shares of Common Stock
Name and Position Year Salary Bonus Underlying Options Other
----------------- ---- ------ ----- ------------------ -----

Alberto DiBella, CEO 2005 $165,000(1) --- --- --
2004 $165,000(1) --- 216,666(3) --
2003 $150,000(2)(3) --- --- (4)

Frank J. DeMicco, 2004 $128,000 --- --- --
Former COO 2003 $150,000 --- 200,000(5) (5)

John A. DiBella, EVP 2005 $150,000(6) --- --- --
2004 $150,000(6) --- 1,033,333(7) --
2003 $150,000(6)(7) --- --- --

(1) Of these amounts, only $43,000 and $25,000 have been paid out for the
years ended December 31, 2005 and 2004, respectively.
Unpaid balance has been included in accrued expenses.
(2) Salary was deferred and subsequently paid during 2004.
(3) In an effort to save the Company money for operating expenses, Mr.
DiBella accrued a significant percentage of his salary. Mr. DiBella
agreed to convert a portion of the accrued salary into options: 110,000
shares of common stock underlying options exercisable at $0.60 per
share and 110,000 shares of common stock underlying options exercisable
at $1.00 per share.
(4) For services rendered during 1997, Mr. DiBella was paid cash
compensation of $50,000 together with 1,000,000 voting convertible,
non-cumulative 8% preferred shares, $0.001 par value. In 1997 Mr.
DiBella also exchanged 5,000,000 shares of common stock for 5,000,000
shares of voting convertible, non-cumulative 8% preferred shares,
$0.001 par value. Effective December 31, 2003, pursuant to its terms,
the preferred stock converted into shares of common stock on a one for
one basis. Mr. DiBella had 6,000,000 shares of preferred stock at the
time of conversion.
(5) Pursuant to Mr. DeMicco's employment agreement, Mr. DeMicco received
warrants to purchase 300,000 shares of the Company's common stock
exercisable at $1.00 per share, subject to certain vesting provisions.
150,000 warrants vested prior to the Company's separation agreement
with Mr. DeMicco. The remaining warrants were terminated. In 2005, Mr.
DeMicco earned 50,000 options as a consultant. Effective December 31,
2005 Mr. DeMicco no longer serves as an executive officer of the
Company.
(6) $145,000, $76,000 and $133,000 have been deferred in 2005, 2004 and
2003, respectively.
(7) In an effort to save the Company money for operating expenses, Mr.
DiBella has accrued a significant percentage of his salary. Mr. DiBella
agreed to convert a portion of the accrued salary from 2001-2003 into
options: 516,666 shares of common stock underlying options exercisable
at $0.60 per share and 516,666 shares of common stock underlying
options exercisable at $1.00 per share.

AGGREGATED FISCAL YEAR-END OPTION VALUE TABLE

The following table sets forth certain information concerning
unexercised stock options as of December 31, 2005 held by executive officers and
directors. The Company has not adopted a formal stock option or equity incentive
plan. All options are vested. No options were exercised during the year ended
December 31, 2005.

Number Of Value Of Unexercised
Unexercised Options In-the-Money
Held at 12/31/05(#) Options at 12/31/05 (1)
------------------- -----------------------

Shares Shares
Name Exercisable Unexercisable Exercisable Unexercisable
---- ----------- ------------- ----------- -------------

Alberto DiBella 220,000 0 $ 0 $0
John DiBella 3,066,666 0 $840,000 $0

(1) The closing sale price of the Common Stock on December 31, 2005 as
reported by OTCBB was $0.57 per share. Value is calculated by
multiplying (a) the difference between $0.57 and the option exercisable
price by (b) the number of shares of Common Stock underlying the
options.

EMPLOYMENT AGREEMENTS

Neither of our executive officers has a written employment agreement
with the Company. However the Company intends to enter into an employment
agreement with John A. DiBella during 2007. We currently pay the CEO and
Executive Vice President approximately $15,000 per month which a high percentage
is accrued.

DIRECTOR COMPENSATION

Directors are not compensated by our Company.

CERTAIN TRANSACTIONS

During the fourth quarter of 2005, John A. DiBella received 1,000,000
shares of common stock from Alberto DiBella.

During the fourth quarter of 2005 Alberto DiBella entered into
agreements with Robert Weinberg and Peter Chiappetta related to personal
advances made by Mr. Weinberg and Mr. Chiappetta to Mr. DiBella. Such advances
were not related to the Company. In full satisfaction of the advances, Mr.
DiBella transferred an aggregate of 5,000,000 shares of the Company's common
stock to Mr. Weinberg and Mr. Chiappetta.

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT

As of January 31, 2007, there were _____ shares of our common stock
outstanding. The table below sets forth information with respect to the
beneficial ownership of our securities as of January 31, 2007 by:

1) each person known by us to be the beneficial owner of five percent
or more of our outstanding securities, and

2) executive officers and directors, individually and as a group.

Unless otherwise indicated, we believe that the beneficial owner has
sole voting and investment power over such shares.

Name and Address of Number of Shares Percentage of
Beneficial Owner Beneficially Owned Ownership
---------------- ------------------ ---------

Alberto DiBella 3,266,666(1) 16.6%
3500 Bayview Drive
Fort Lauderdale, FL 33308

John A. DiBella 4,033,333(2) 17.9%
821 N.W. 57th Place
Fort Lauderdale, FL 33309

Robert Weinberg 2,000,000(3) 10.3%
11338 Clover Leaf Circle
Boca Raton, FL 33428

Peter Chiappetta 3,000,000(3) 15.4%
2299 NW 62nd Drive
Boca Raton, FL 33487

All officers and directors 7,299,999 34.5%
as a group (2 persons)

(1) Alberto DiBella's beneficial share ownership includes 10,000 shares of
common stock owned by his wife. Also includes 110,000 shares of common
stock underlying options exercisable at $0.60 per share and 110,000
shares of common stock underlying options exercisable at $1.00 per share.

(2) Includes 2,000,000 shares of common stock underlying options exercisable
at $0.15 per share, 516,666 shares of common stock underlying options
exercisable at $0.60 per share and 516,666 shares of common stock
underlying options exercisable at $1.00 per share. Excludes shares, which
Mr. DiBella holds voting control, but does not hold any power to dispose
of such shares. See footnote 3.

(3) Voting rights of said shares were granted to John A. DiBella until such
time the percentage ownership is less than 3% of the Company.

DESCRIPTION OF SECURITIES

As of January 31, 2007, we had authorized 42,750,000 shares of par
value $0.001 common stock, with 21,992,235 shares issued and outstanding.
Additionally, we have authorized 7,250,000 shares of preferred stock, with no
shares issued and outstanding.

COMMON STOCK

The holders of common stock are entitled to one vote for each share
held of record on all matters to be voted on by shareholders. There is no
cumulative voting with respect to the election of directors, with the result
that the holders of more than 50% of the shares voted for the election of
directors can elect all of the directors. The holders of common stock are
entitled to receive dividends when, as and if declared by the board of directors
out of funds legally available therefor. In the event of our liquidation,
dissolution or winding up, the holders of common stock are entitled to share
ratably in all assets remaining available for distribution to them after payment
of liabilities and after provision has been made for each class of stock, if
any, having preference over the common stock. Holders of shares of common stock,
as such, have no conversion, preemptive or other subscription rights, and there
are no redemption provisions applicable to common stock. All of the outstanding
shares of common stock are, and the shares of common stock offered hereby, will
be duly authorized, validly issued, fully paid and nonassessable.

PREFERRED STOCK

We are authorized to issue shares of preferred stock with such
designation, rights and preferences as may be determined from time to time by
the board of directors. Accordingly, the board of directors is empowered,
without shareholder approval, to issue preferred stock with dividend,
liquidation, conversion, voting or other rights that could adversely affect the
voting power or other rights of the holders of the common stock. In the event of
issuance, the preferred stock could be utilized, under certain circumstances, as
a method of discouraging, delaying or preventing a change in control. As of the
date of this Prospectus we have no outstanding shares of preferred stock.

WARRANTS

As of the date of this prospectus, we had outstanding warrants to
purchase 5,438,698 shares of our common stock exercisable at the following
prices:

As of the date of this prospectus we had outstanding options to
purchase 4,104,666 shares of our common stock exercisable at the following
prices:

The warrants and options expire on various dates from February, 2007 to
August, 2011. The warrants may be called or repurchased at $0.001 per underlying
share of common stock provided the closing bid price for the Company's Common
Stock is at or above $2.00 per share for twenty consecutive trading days within
30 days of the Company's written notice of the Company's intention to call this
warrant. In the event this warrant has not been exercised by written notice
within 30 days of such notice, the warrant will cease to exist.

TRANSFER AGENT

The Transfer Agent for our shares of common stock is Jersey Transfer &
Trust, Inc., 201 Bloomfield Ave., Verona, NJ 07044. The telephone number for
Jersey Transfer & Trust, Inc is (973) 239-2712.

SELLING SHAREHOLDERS

This prospectus relates to the registration of 9,543,363 shares of our
common stock underlying certain warrants and options held by various parties
listed below. We will not receive any proceeds from the sale our common stock by
the selling shareholders. However, we may receive up to $11,166,883.80 of
proceeds from the options and warrants exercisable to acquire the shares of
common stock we are registering under this prospectus. Any proceeds from the
exercise of options and warrants will be used for working capital. The selling
shareholders may resell the shares they acquire by means of this prospectus from
time to time in the public market. The costs of registering the shares offered
by the selling shareholders are being paid by us. The selling shareholders will
pay all other costs of the sale of the shares offered by them.

The following table sets forth the name of the selling shareholders,
the number of common shares that may be offered by the selling shareholders and
the number of common shares to be owned by the selling shareholders after the
offering. The table also assumes that each selling shareholder sells all common
shares listed by its name. The table below sets forth information as of the date
of this prospectus. The percentage calculations for the selling shareholders do
not include any common shares issuable upon the exercise of any currently
outstanding warrants, options or other rights to acquire common shares, other
than those that the selling shareholders beneficially own. Unless otherwise
noted below, the address for the selling shareholder is 821 N.W. 57th Place,
Fort Lauderdale, Florida 33309.

Common Shares Common Shares Common Shares
Owned Prior Offered Owned After
to Offering in the Offering the Offering
Name of Shareholder Number Percentage Number Number Percentage
------------------- ------ ---------- ------ ------ ----------

John M. and Gail S. Antonakos, JTWROS 20,000 * 20,000(1) 0 *
1079 Route 523
Flemington, NJ 08822

Glen B. Bagnall 6,000 * 6,000(1) 0 0
24111 Meridian Rd #117
Grosse, Lle MI 48138

Paul Bendigo 4,000 * 4,000(1) 0 0
250 Dickinson Drive
Reading, PA 19605

Thomas W. Bilowus 2,000 * 2,000(1) 0 0
4553 Lake Ave
Blasdell, NY 14219-1303

Ruth Butler 124,000 * 16,000(1) 108,000 *
207 Sharon Pkwy
Lackawanna, NY 14218

Agatino Cintorrino 72,600 * 38,400(1)(4) 34,200 *
37 W. Main Street
Somerville, NJ 08876

Kenneth G. Conrad 66,334 * 38,667(1)(4) 27,667 *
2935 Rising Sun Road
Slatington, PA 18080

James Dahme 39,334 * 22,667(1)(4) 16,667 0
1237 Yellow Springs Road
Chester Springs, PA 19425

Joseph Di Bella 70,000 * 35,000(1)(4) 35,000 *
10 Sandy Hill Rd.
Westfield, NJ 07090

Rita DiPalo 18,100 * 8,933(1)(4) 9,167 *
1008 Featherbed Lane
Edison, NJ 08820

Paul J. and Linda A. Fischl 2,000 * 2,000 0 *
760 Point Phillips Road
Bath, PA 18014

Donald Hughes 4,000 * 4,000 0 *
2101 Springhouse Road
Broomal, PA 19008

Hal P. Johnson 6,000 * 6,000 0 *
P.O. Box 2557
West Lawn, PA 19609

Ralph Liloia 2,000 * 2,000 0 *
11 Liverpool Ct.
Toms River, NJ 08753

Paul J. Mueller 6,000 * 6,000 0 *
3045 Van Alstyne
Wyandotte, MI 48192

Joseph E. Mueller 8,000 * 8,000 0 0
28437 Balmoral
Garden City, MI 48135

Linda Rammage 10,000 * 10,000 0 0
8112 W Six Mile Rd
Northville, MI 48167

John L. Rowe 57,334 * 28,667(1)(4) 22,667 *
356 Magnolia Road
Warminster, PA 18974

Paul J. and Marie Sharga, JTWROS 30,000 * 20,000 10,000 *
1515 Newport Avenue
Northampton, PA 18067

Edward G. Brown and
Janet M. Nickerson 2,000 * 2,000 0 *
RR 2 Box 2440
Leeds, ME 04263

Arnold J. Solof 8,000 * 8,000 0 *
1816 Redwood Drive
Vineland, NJ 08361-6750

Jeffrey P. Szackas 2,000 * 2,000 0 *
23G Greentop Road
Sellersville, PA 18960

Susan V Timmreck 4,000 * 4,000 0 *
901 Cedar Street
Millville, NJ 08332

Michael & Antoinetta Ulisse 17,700 * 8,533(1)(2) 9,167 *
17 Lynwood Road
Edison, NJ 08820

Ellen Van Embden 2,000 * 2,000 0 0
3312 Sherwood Road
Easton, PA 18045

Nathan Van Embden 4,000 * 4,000 0 0
787 Hogbin Road, P.O. Box 1641
Millville, NJ 08332

Karen Van Embden 4,000 * 4,000 0 0
807 South Fountain
Wichita, KS 67218

Paul Van Embden 2,000 * 2,000 0 0
1007 Cedar
Millville, NJ 08332

Laura Van Embden 4,000 * 4,000 0 *
1007 Cedar Street
Millville, NJ 08332

Julie Van Embden 4,000 * 4,000 0 *
4132 Garfield Avenue
Pennsauken, NJ 08109

Phillip S. Van Embden 6,000 * 6,000 0 *
P.O. Box 863
Millville, NJ 08332

Richard Williams 2,000 * 2,000 0 *
998 Newichawnoe Lane
Bath, PA 18014

Roland W. and Dianne S. Woodall 4,000 * 4,000 0 *
R.D. #3 Box 609C
Charleroi, PA 15022

William Lanzana 30,000 * 20,000 10,000 *
577 Chestnut Ridge Road
Woodcliff Lake, NJ 07675

Kevin Johnson 300,000 200,000(2) 100,000 *
7106 Matthews Rd.
Durham, NC 27712

Joan Rich Baer, Inc. (14)
Pension Plan & Trust 330,000 * 140,000(3)(4) 0 *
199 Concord Drive
Madison, CT 06443

RBG Residuary Trust (15) 950,000 3.2% 600,000(3)(4) 350,000 *
8 North Rohallion Drive
Rumson, NJ 07760

Richard Goodwyn 150,000 * 100,000 50,000 *
8 North Rohallion Drive
Rumson, NJ 07760

The Whittier Trust Company (16) 249,999 * 166,666 83,333 *
of Nevada, Inc.
Trustee of the Haldan
Grandchildren's Trust
fbo Seth H. Casden
100 West Liberty Street, Suite 890
Reno, NV 89501

The Whittier Trust Company (17)
of Nevada, Inc.
Trustee of the Haldan
Grandchildren's Trust
fbo Graham S. Casden 333,333 * 208,333(3)(4) 125,000 *
100 West Liberty Street, Suite 890
Reno, NV 89501

Harrichand Persaud 333,332 * 166,666(4) 166,000 *
264 Airmont Ave.
Mahwah, NJ 07430

Barbara J. Drew TTEE for the
Barbara J. Drew Revocable
Living Trust (22) 166,666 * 83,333(4) 83,333 *
302 Carl Lane
Capitola, CA 95010

Robert Agriogianis 41,666 * 41,666(4) 0 *
16 Harvale Drive
Florham Park, NJ 07932

Michael H. Lambert 16,667 * 16,667(4) 0 *
2020 Pintail Drive
Longmont, CO 80504

Richard Zimmer 41,667 * 41,667(4) 0 *
136 Locktown-Flemington Road
Flemington, NJ 08822

Dominic Spinosa 83,332 * 83,332(4) 0 *
1766 Roland Ave.
Wantagh, NY 11793-2856

Peter Maciak 250,000 * 125,000(4) 125,000 *
125 Krager Road
Binghamton, NY 13904

Keys Family Trust (18) 100,000 * 50,000(4) 50,000 *
1024 Glorietta
Coronado, CA 92118

William Dorfman 83,334 * 41,667(4) 41,667 *
Century Park East- Suite 1601
LA, CA 90067

Barry Gafner 180,000 * 95,000(4)(13) 85,000 *
4560 St. Vrain Road
Longmont, CO, 80503

Donald Cameron Rodee 333,332 * 166,666(4) 166,666 *
1510 Wilshire Road
Fallbrook, CA 92028

Kevin Mulshine 80,000 (3)(14) * 45,000(4)(13) 35,000 *
4097 St. Lucia Street
Boulder, CO 80301

Mustafa Chike-Obi 83,334 * 41,667(4) 41,667 *
175 Brooklake Road
Florham Park, NJ 07932

James P. Kearney 83,334 * 41,667(4) 41,667 *
59 Union Hill Road
Madison, NJ 07940

Paul J. Sharga 16,667 * 16,667(4) 0 *
1515 Newport Ave.
Northampton, PA 18067

John W. & Barbara B. Hemmer 41,667 * 16,667(4) 25,000 *
88 Meadow Road
Briarcliff Manor, NY 10510

Frank J. DeMicco 200,000 (5) * 200,000(5) 0 *
1000 Williams Island Blvd. Ste 3102
Aventura, FL 33160

Kim J. Gloystein 33,333 * 33,333(6) 0 0
7430 S Indian Lake Drive
Vicksburg, MI 49097

Richard T. Huebner IRA 80,000 * 80,000(6) 0 0
16318 E. Berry Ave.
Centennial, CO 80015

Steven M. Bathgate IRA 665,071 2.2% 366,667(6) 298,404 *
6376 E. Tufts Ave.
Englewood, CO 80111

Michael J. Beaudoin 40,000 * 20,000(6) 20,000 *
2915 Miwall Ct.
Castlerock, CO 80109

David W. Beaudoin 40,000 * 20,000(6) 20,000 *
21544 Tullman Drive
Parker, CO 80111

John R. Cohagen 66,666 * 33,333(6) 33,333 *
3939 95th St.
Boulder, CO 80301

John David Kucera IRA 26,666 * 13,333(6) 13,333 *
6178 S. Alton Way
Greenwood Village, CO 80111

Pamela M. Kelsall IRA 33,334 * 16,667(6) 16,667 *
6117 E. Princeton Ave.
Englewood, CO 80111

Douglas H. Kelsall IRA 66,666 * 33,333(6) 33,333 *
6117 E. Princeton Ave.
Englewood, CO 80111

Eugene C. McColley IRA 50,000 * 50,000(6) 0 0
3900 Garden Ave.
Greenwood Village, CO 80121

Greg Fulton IRA 33,334 * 16,667(6) 16,667 *
5520 South Newport Street
Greenwood Village, CO 81111

Ann Fulton IRA 33,334 * 16,667(6) 16,667 *
5520 South Newport Street
Greenwood Village, CO 81111

Sandra Garnet C/F Colin Garnett 66,666 * 33,333(6) 33,333 *
1301 Pennsylvania Street, Suite 800
Denver, CO 80203

Sandra Garnet C/F Aaron Garnett 66,666 * 33,333(6) 33,333 *
1301 Pennsylvania Street, Suite 800
Denver, CO 80203

Sandra Garnett C/F Benjamin Garnett 66,666 * 33,333(6) 33,333 *
1301 Pennsylvania Street, Suite 800
Denver, CO 80203

Lee E. Schlessman 266,666 * 133,333(6) 133,333 *
1301 Pennsylvania Street, Suite 800
Denver, CO 80203

Rodney Garnett, Lee Schlessman POA 66,666 * 33,333(6) 33,333 *
1301 Pennsylvania Street, Suite 800
Denver, CO 80203

Sandra L. Garnett,
Lee E. Schlessman POA 66,666 * 33,333(6) 33,333 *
1301 Pennsylvania Street, Suite 800
Denver, CO 80203

Gary L. Schlessman
C/F Margaret Schlessman 33,334 * 16,667(6) 16,667 *
1301 Pennsylvania Street, Suite 800
Denver, CO 80203

Gary Schlessman
C/F Jennifer Schlessman 33,334 * 16,667(6) 16,667 *
1301 Pennsylvania Street, Suite 800
Denver, CO 80203

Cheryl S. Bennett C/F Eric Bennett 33,334 * 16,667(6) 16,667 *
1301 Pennsylvania Street, Suite 800
Denver, CO 80203

Cheryl S. Bennett,
Lee Schlessman POACO 66,666 * 33,333(6) 33,333 *
1301 Pennsylvania Street, Suite 800
Denver, CO 80203

Cheryl S. Bennett
C/F Lauren M. Bennett 33,334 * 16,667(6) 16,667 *
1301 Pennsylvania Street, Suite 800
Denver, CO 80203

George Johnson IRA 40,000 * 40,000(6) 0 0
6 Churchill Dr.
Englewood, CO 80113

Kent J. Lund 17,000 * 17,000(6) 0 0
203 S Pontiac St.
Denver, CO 80230

George Irwin Lind III IRA 66,667 * 66,667(6) 0 0
#2 Drive Lane
Littleton, CO 80123

Steven D. Plissey IRA 34,000 * 17,000(6) 17,000 *
2225 Witter Gulch
Evergreen, CO 80439

Frederic Duboc IRA 200,000 * 100,000(6) 100,000 *
5500 Pemberton Drive
Greenwood Village, CO 80121

Keysten Investments Ltd. (19) 333,333 * 333,333(6) 0 0
Suite 5050, Commerce Court West 199 Bay Street
Toronto, ON 5ML-1E2

James Edgar McDonald Revocable
Living Trust Dated 6/30/95 (20) 60,000 * 30,000(6) 30,000 *
6044 E Briarwood Dr
Centennial, CO 80112

Virginia Stevens McDonald Revocable
Living Trust Dated 6/30/95 (21) 30,000 * 30,000(6) 0 0
6044 E Briarwood Dr.
Centennial, CO 80112

Robert H. Aukerman 30,000 * 20,000(6) 10,000 *
6077 S. Cathay Ct.
Aurora, CO 80016

Thomas D. Wolf 40,000 * 20,000(6) 20,000 0
5751 E Nassau Place
Englewood, CO 80111

Christopher J. Koenigs/
Jeanne F. Collopy JTWRDS 34,000 * 17,000(6) 17,000 *
2433 E 7th Ave
Denver, CO 80206

Roger Conan 120,000 * 60,000(6) 60,000 *
14 Oaklay Rd
Dublin 6, Ireland

Richard Vernon Wilsey 68,000 * 34,000(6) 34,000 *
P.O. Box 432
Morrison, CO 80465

David L. Gertz 68,000 * 34,000(6) 34,000 *
7120 E Orchard Rd, Suite 300
Centennial, CO 80111

Vicki D.E. Barone IRA 16,000 * 16,000(6) 0 0
7854 S Harrison Cir.
Littleton, CO 80122

Bathgate Capital Partners (22) 530,500 * 530,500(7) 0 0
5350 South Roslyn St., Ste 400
Greenwood Village, CO 80111

John A. DiBella 4,033,333 17.9% 3,066,666(9)(12) 966,667 3.3%
821 NW 57th Place
Fort Lauderdale, FL 33309

Daniel Samela 45,000 * 45,000(8) 0 0
4072 Oxbow Dr.
Coconut Creek, FL, 33073

Laura DiBella 200,000 * 200,000(10) 0 0
3500 Bayview Dr.
Ft. Lauderdale, FL 33301

Dan Leon 10,000 * 10,000(11) 0 0
4940 NW 85 Ave
Lauderhill, FL 33351

Alberto DiBella 3,266,666 11% 220,000(12) 3,046,666 10%
3500 Bayview Dr.
Ft. Lauderdale, FL 33301

J. John Combs 483,000 * 483,000(12) 0 0
6494 Nelson Rd
Longmont CO 80503

Henry Schlesinger 10,000 * 10,000(13) 0 0
18802 Pheasant Lane
Tomball, TX 77377

Total: 9,543,363

* Denotes ownership of less than 1%. Percentage ownership assumes complete sale
of securities into the open market after exercise of warrants or options. Some
investors have invested on more than 1 occasion. Their total ownership is shown
only once in Column A.

(1) Includes warrants issued through a private placement conducted in
February 2000. In the first half of 2000, we raised $364,800 through
the private placement of our securities. We sold 1,216 units to 34
accredited investors. Each unit was comprised of one hundred shares of
restricted common stock and 200 warrants, one hundred exercisable at
$6.00 and one hundred exercisable at $9.00. A total of 243,200 warrants
were issued in this Offering, which includes 121,600 warrants
exercisable at $6.00 and 121,600 warrants exercisable at $9.00. The
issuances were exempt from registration under Section 4(2) of the
Securities Act. The investors received information concerning the
Company and had the opportunity to ask questions concerning the
viability of the Company. The shares contain legends restricting their
transferability absent registration or applicable exemption.

(2) Includes warrants issued through a private offering in April 2001. In
April 2001, we raised $100,000 through the private placement of our
securities. We sold 1,000 units containing share of our common stock
and warrants to one accredited investor. Each unit was comprised of 100
shares of restricted common stock and 200 common stock purchase
warrants, of which 100 warrants are exercisable at $3.00 per share and
100 warrants are exercisable at $4.00 per share. A total of 200,000
warrants were issued in this Offering, which includes 100,000 warrants
36

exercisable at $3.00 and 100,000 warrants exercisable at $4.00. The
issuances were exempt from registration under Section 4(2) of the
Securities Act. The investors received information concerning the
Company and had the opportunity to ask questions concerning the
viability of the Company. The shares contain legends restricting their
transferability absent registration or applicable exemption.

(3) Includes warrants issued through a private placement in fiscal year
2002. During the year ended December 31, 2002, we sold 5.17 units of
securities at $60,000 per unit in a private placement to 5 investors.
Each unit consisted of 100,000 shares of common stock, 100,000 warrants
to purchase 100,000 shares of common stock at an exercise price of
$1.00 per share and 100,000 warrants to purchase 100,000 shares of
common stock at an exercise price of $1.25 per share. The warrants
issued at $1 per share are callable at par value provided the stock
trades above $1.50 per share for 20 consecutive trading days. The
warrants issued at $1.25 per share are callable at par value provided
the stock trades above $2 per share for 20 consecutive trading days.
Net proceeds received by our Company aggregated $286,000. The warrants
are exercisable from the date of issuance through December 2007. A
total of 1,033,332 warrants were issued in this Offering, which
includes 516,666 warrants exercisable at $1.00 and 516,666 warrants
exercisable at $1.25. The issuances were exempt from registration under
Section 4(2) of the Securities Act. The investors received information
concerning the Company and had the opportunity to ask questions
concerning the viability of the Company. The shares contain legends
restricting their transferability absent registration or applicable
exemption.

(4) Includes warrants issued through a private placement, which commenced
in 2003 and was closed in January 2004. Under the private placement we
sold an aggregate of 8.08 units of securities to 30 investors for
proceeds of $808,000. Each unit consisted of 166,666 shares of
restricted common stock at $0.60 per share and 166,666 warrants to
purchase 166,666 shares of common stock at $1.00 per share. The
warrants are exercisable for a period of five years from the date of
closing. The investors received information concerning our company and
had the opportunity to ask questions to the viability of our company. A
total of 1,346,665 warrants were issued in this Offering. The issuances
were exempt from registration under Section 4(2) of the Securities Act.
The investors received information concerning the Company and had the
opportunity to ask questions concerning the viability of the Company.
The shares contain legends restricting their transferability absent
registration or applicable exemption.

(5) Effective January 1, 2003, we issued warrants to purchase 300,000
shares of our common stock exercisable at $1.00 per share to Frank
DeMicco pursuant to Mr. DeMicco's five-year employment contract with
our company. Warrants to purchase 100,000 shares vested during year
ended December 31, 2003 and the remaining warrants vest periodically
over the term of the agreement. The balance 150,000 warrants were
cancelled due to the mutual termination of DeMicco's employment
contract. In January 2005, the Company entered into a one-year
consulting agreement with Mr. DeMicco for engineering design, marketing
and sales of Company products and services. Pursuant to this agreement,
the Company granted 50,000 options to Mr. DeMicco exercisable at $1.00
per share. These options vest equally in 12 traunches over a period of
one year commencing in January, 2005 and expire in January 2008. The
options and warrants issued to Mr. DeMicco were exempt from
registration under Section 4(2) of the Securities Act. The options and
warrants contain the appropriate restrictive legend restricting their
37

transferability absent registration or applicable exemption. Mr.
DeMicco received information concerning our company and had the
opportunity to ask questions about the viability of our company.

(6) Includes warrants issued through a private placement in fiscal year
2004. From May 2004 through August 2004, the Company sold an aggregate
of 1,935,000 units of securities to 38 accredited investors for gross
proceeds of $1,451,250 under the private placement (Schedule D). The
Company paid Bathgate Capital Partners, a placement agent, a commission
of 10% of the gross proceeds and a non-accountable expense allowance of
3% of the gross proceeds and issued the placement agent warrants to
purchase six shares of common stock (three shares at $0.75 and three
shares at $1.00) for each 20 units sold in the offering. Each unit
consisted of one share of restricted common stock at $0.75 per share
and one warrant to purchase one share of common stock at $1.00 per
share. The warrants are exercisable for a period of five years from the
date of closing. A total of 1,935,000 warrants were issued in this
offering. The issuances were exempt from registration under Section
4(2) of the Securities Act. The investors received information
concerning the Company and had the opportunity to ask questions
concerning the viability of the Company. The shares contain legends
restricting their transferability absent registration or applicable
exemption.

(7) Includes the number of warrants issued to Bathgate Capital Partners as
commissions for the private placement discussed above. The Company has
paid Bathgate Capital Partners, a placement agent, a commission of 10%
of the gross proceeds and a non-accountable expense allowance of 3% of
the gross proceeds and issued the placement agent warrants to purchase
six shares of common stock (three shares at $0.75 and three shares at
$1.00) for each 20 units sold in the offering. Each unit consisted of
one share of restricted common stock at $0.75 per share and one warrant
to purchase one share of common stock at $1.00 per share. The warrants
are exercisable for a period of five years from the date of closing.
The transactions were exempt from registration under Section 4(2) of
the Securities Act. Bathgate Capital Partners was deemed accredited.
The investors received information concerning the Company and had the
opportunity to ask questions concerning the viability of the Company.
The shares and warrants contain legends restricting their
transferability absent registration or applicable exemption. A total of
530,000 warrants were issued to Bathgate Capital Partners, which
includes 265,250 warrants exercisable at $0.75 and 265,250 warrants
exercisable at $1.00.

(8) During November 2001 we issued options to purchase 45,000 shares of our
common stock exercisable at $0.30 per share to an individual pursuant
to an employment agreement with our company. The options vest
periodically over the term of the agreement. The options issued to the
employee were exempt from registration under Section 4(2) of the
Securities Act. The options contain the appropriate restrictive legend
restricting their transferability absent registration or applicable
exemption. The employee received information concerning our company and
had the opportunity to ask questions about the viability of our
company.

(9) On January 17, 2002, we issued options to purchase 2,000,000 shares of
our common stock at an exercise price of $0.15 per share. The market
price at the date of the grant was $0.12 per share. These options were
issued pursuant to an employment agreement. The options vest
periodically over the term of the agreement. The options issued to the
employee were exempt from registration under Section 4(2) of the
Securities Act. The options contain the appropriate restrictive legend
38

restricting their transferability absent registration or applicable
exemption. The employee received information concerning our company and
had the opportunity to ask questions about the viability of our
company.

(10) During year ended December 31, 2002, we issued stock options to
purchase 200,000 shares of common stock to an additional employee of
our Company. These options have an exercise price of $0.77 per share.
The options vest periodically over the term of the agreement. The
options issued to the employee were exempt from registration under
Section 4(2) of the Securities Act. The options contain the appropriate
restrictive legend restricting their transferability absent
registration or applicable exemption. The employee received information
concerning our company and had the opportunity to ask questions about
the viability of our company.

(11) During January of 2003 we issued options to purchase 10,000 shares of
our common stock exercisable at $1.00 per share to an employee pursuant
to a two-year employment agreement with our company. The options vest
periodically over the term of the agreement, of which options to
purchase 5,000 shares vested during year ended December 31, 2003. The
options issued to the employee were exempt from registration under
Section 4(2) of the Securities Act. The options contain the appropriate
restrictive legend restricting their transferability absent
registration or applicable exemption. The employee received information
concerning our company and had the opportunity to ask questions about
the viability of our company.

(12) During the 2004 fiscal year, we issued options to purchase an aggregate
of 1,394,666 shares of our common stock to our chief executive officer,
an employee and a consultant in consideration for such individuals
converting accrued salaries and consulting fees in the aggregate amount
of $370,000 to equity in our Company. Options to purchase 697,333
shares of our common stock are exercisable at $0.60 and options to
purchase 697,333 shares of our common stock are exercisable at $1.00.
The options are exercisable for a period of five years commencing
January 15, 2004. Options to purchase 220,000 shares of our common
stock were issued to Alberto DiBella. Options to purchase 1,066,666
shares of our common stock were issued to John A. DiBella. Options to
purchase 108,000 shares of our common stock were issued to John Combs.
The issuance of the options to our employees was exempt from
registration under Section 4(2) of the Securities Act. The employees
had access to information concerning our Company and had the
opportunity to ask questions concerning the viability of our Company.
The options issued to our employees contain legends restricting their
transferability absent registration or applicable exemption.

(13) On February 18, 2004, we issued options to purchase an aggregate of
30,000 shares of our common stock exercisable at $0.71 per share to
three individuals as consideration for joining our advisory committee.
The options are exercisable until February 18, 2006. The options were
issued pursuant to the exemption from registration under Section 4(2)
of the Securities Act. The advisors received information concerning our
Company and had the opportunity to ask questions concerning the
viability of our Company. The options contain legends restricting their
transferability absent registration or applicable exemption.

(14) Dispostive control held by _____________________.

(15) Dispostive control held by _____________________.

(16) Dispostive control held by _____________________.

(17) Dispostive control held by _____________________.
39

(18) Dispostive control held by _____________________.

(19) Dispostive control held by _____________________.

(20) Dispostive control held by _____________________.

(21) Dispostive control held by _____________________.

(22) Dispostive control held by _____________________.

PLAN OF DISTRIBUTION

The shares of common stock owned, or which may be acquired, by the
selling shareholders may be offered and sold by means of this prospectus from
time to time as market conditions permit in the over-the-counter market, or
otherwise, at prices and terms then prevailing or at prices related to the
then-current market price, or in negotiated transactions. These shares may be
sold by one or more of the following methods, without limitation:

o a block trade in which a broker or dealer so engaged will attempt
to sell the shares as agent but may position and resell a portion
of the block as principal to facilitate the transaction;

o purchases by a broker or dealer as principal and resale by such
broker or dealer for its account pursuant to this prospectus;

o ordinary brokerage transactions and transactions in which the
broker solicits purchasers; and

o face-to-face transactions between sellers and purchasers without
a broker/dealer.

In effecting sales, brokers or dealers engaged by the selling
shareholders may arrange for other brokers or dealers to participate. Such
brokers or dealers may receive commissions or discounts from selling
shareholders in amounts to be negotiated.

The selling shareholders and any broker/dealers who act in connection
with the sale of the shares hereunder may be deemed to be "underwriters" within
the meaning of section 2(11) of the Securities Acts of 1933, and any commissions
received by them and profit on any resale of the shares as principal might be
deemed to be underwriting discounts and commissions under the Securities Act. We
have agreed to indemnify the selling shareholders, and any securities
broker/dealers who may be deemed to be underwriters against certain liabilities,
including liabilities under the Securities Act as underwriters or otherwise.

We have advised the selling shareholders that they and any securities
broker/dealers or others who may be deemed to be statutory underwriters will be
subject to the prospectus delivery requirements under the Securities Act. We
have also advised each selling shareholder that in the event of a "distribution"
of the shares owned by the selling shareholder, such selling shareholder, any
"affiliated purchasers", and any broker/dealer or other person who participates
in such distribution, may be subject to Rule 102 under the Securities Exchange
Act of 1934 until their participation in that distribution is completed. Rule
102 makes it unlawful for any person who is participating in a distribution to
bid for or purchase stock of the same class as is the subject of the
distribution. A "distribution" is defined in Rule 102 as an offering of
securities "that is distinguished from ordinary trading transactions by the
magnitude of the offering and the presence of special selling efforts and
selling methods". We have also advised the selling shareholders that Rule 101

under the 1934 Act prohibits any "stabilizing bid" or "stabilizing purchase" for
the purpose of pegging, fixing or stabilizing the price of the common stock in
connection with this offering.

We do not intend to distribute or deliver the prospectus by means other
than by hand or mail.

During such time as the selling shareholders may be engaged in a
distribution of the securities covered by this prospectus, the selling
shareholders are required to comply with Regulation M promulgated under the
Exchange Act. With certain exceptions, Regulation M precludes the selling
shareholders, any affiliated purchasers, and any broker-dealer or other person
who participates in such distribution from bidding for or purchasing, or
attempting to induce any person to bid for or purchase any security which is the
subject to the distribution until the entire distribution is complete.
Regulation M also restricts bids or purchases made in order to stabilize the
price of a security in connection with the distribution of that security. All of
the foregoing may affect the marketability of our common stock.

SHARES ELIGIBLE FOR FUTURE SALE

As of the date of this prospectus, we have 21,492,235 shares of common
stock issued and outstanding. This does not include shares that may be issued
upon exercise of options or warrants.

We cannot predict the effect, if any, that market sales of common stock
or the availability of these shares for sale will have on the market price of
our shares from time to time. Nevertheless, the possibility that substantial
amounts of common stock may be sold in the public market could negatively damage
and affect market prices for our common stock and could damage our ability to
raise capital through the sale of our equity securities.

LEGAL MATTERS

The validity of the securities offered by this prospectus will be
passed upon for us by Arnstein & Lehr LLP, 200 East Las Olas Boulevard, Suite
1700, Fort Lauderdale, Florida 33301.

EXPERTS

Our consolidated financial statements as of December 31, 2005 are
included herein in reliance on the reports Jewett, Schwartz, Wolfe & Associates
& Co., LLP independent accountants, given on the authority of that firm as
experts in accounting and auditing.

ADDITIONAL INFORMATION

We have filed with the SEC the registration statement on Form SB-2
under the Securities Act for the common stock offered by this prospectus. This
prospectus, which is a part of the registration statement, does not contain all
of the information in the registration statement and the exhibits filed with it,
portions of which have been omitted as permitted by SEC rules and regulations.
For further information concerning us and the securities offered by this
prospectus, we refer to the registration statement and to the exhibits filed
with it. Statements contained in this prospectus as to the content of any
contract or other document referred to are not necessarily complete. In each
instance, we refer you to the copy of the contracts and/or other documents filed
as exhibits to the registration statement, and these statements are qualified in
their entirety by reference to the contract or document.

The registration statement, including all exhibits, may be inspected
without charge at the SEC's Public Reference Room at 450 Fifth Street, N.W.
Washington, D.C. 20549, and at the SEC's regional offices located at the
Woolworth Building, 233 Broadway, New York, New York 10279 and Citicorp Center,
500 West Madison Street, Suite 1400, Chicago, Illinois 60661. Copies of these
materials may also be obtained from the SEC's Public Reference at 450 Fifth
Street, N.W., Room 1024, Washington D.C. 20549, upon the payment of prescribed
fees. You may obtain information on the operation of the Public Reference Room
by calling the SEC at 1-800-SEC-0330.

The registration statement, including all exhibits and schedules and
amendments, has been filed with the SEC through the Electronic Data Gathering,
Analysis and Retrieval system, and are publicly available through the SEC's Web
site located at http://www.sec.gov.

ENVIRO VORAXIAL TECHNOLOGY, INC.
AND SUBSIDIARY

FINANCIAL STATEMENTS

DECEMBER 31, 2005 and 2004

Table of Contents

Report of Independent Registered Public Accounting Firm................................ F - 2

Balance Sheet ......................................................................... F - 3

Statements of Operations ............................................................ F - 4

Statements of Changes in Shareholders' Deficiency.................................... F - 5

Statements of Cash Flows ........................................................... F - 6

Notes to Financial Statements.......................................................... F7-F-16

Report of Independent Registered Public Accounting Firm

To The Shareholders and Board of Directors of
Enviro Voraxial Technology, Inc.

We have audited the accompanying consolidated balance sheet of Enviro Voraxial
Technology, Inc and Subsidiary as of December 31, 2005 and 2004 and the related
consolidated statements of operations, changes in shareholders' deficiency and
cash flows for the years then ended. These financial statements are the
responsibility of the Company's management. Our responsibility is to express an
opinion on these financial statements based on our audits.

We conducted our audit in accordance with the standards of the Public Company
Accounting Oversight Board (United States). Those standards require that we plan
and perform the audit to obtain reasonable assurance about whether the financial
statements are free of material misstatement. An audit includes examining, on a
test basis, evidence supporting the amounts and disclosures in the financial
statements. An audit also includes assessing the accounting principles used and
significant estimates made by management, as well as evaluating the overall
financial statement presentation. We believe that our audits provided a
reasonable basis for our opinion.

In our opinion, the financial statements referred to above present fairly, in
all material respects, the financial position of Enviro Voraxial Technology, Inc
and Subsidiary as of December 31, 2005 and 2004, and the results of its
operations and its cash flows for the years then ended in conformity with
accounting principles generally accepted in the United States.

The accompanying consolidated financial statements have been prepared assuming
that Enviro Voraxial Technology, Inc and Subsidiary will continue as a going
concern. As discussed in Note B to the financial statements, Enviro Voraxial
Technology, Inc and Subsidiary has suffered recurring losses from operations,
which raises substantial doubt about its ability to continue as a going concern.
Management's plans regarding those matters also are described in Note B. The
financial statements do not include any adjustments that might result from the
outcome of this uncertainty.

Jewett, Schwartz, & Associates

Hollywood, Florida
April 11, 2006

F-2

ENVIRO VORAXIAL TECHNOLOGY, INC. AND SUBSIDIARY

CONSOLIDATED BALANCE SHEET

December 31,
2005
------------------

ASSETS

CURRENT ASSETS:
Cash and cash equivalents $ 76,691
Inventory 126,034
------------------

Total current assets 202,725

FIXED ASSETS, NET 5,338

OTHER ASSETS 10,000
------------------

Total assets $ 218,063
==================

LIABILITIES AND SHAREHOLDERS' DEFICIENCY

CURRENT LIABILITIES:
Accounts payable and accrued expenses $ 424,703
------------------

Total current liabilities 424,703
------------------

Total liabilities 424,703
------------------

COMMITMENTS AND CONTINGENCIES

SHAREHOLDERS' DEFICIENCY:
Common stock, $.001 par value, 42,750,000 shares authorized
19,459,735 shares issued and oustanding 19,459
Additional paid-in capital 5,709,343
Deferred compensation (53,437)
Accumulated deficit (5,882,005)
------------------

Total shareholders' deficiency (206,640)
------------------

Total liabilities and shareholders' deficiency $ 218,063
==================

The accompanying notes are an integral part of the
consolidated financial statements

F-3

ENVIRO VORAXIAL TECHNOLOGY, INC. AND SUBSIDIARY

CONSOLIDATED STATEMENTS OF OPERATIONS

Years Ended December 31,
------------------------------------------------------
2005 2004
------------------------ -------------------------

Revenues, net $ 128,070 $ 19,000

Cost of goods sold 34,444 -
------------------------ -------------------------

Gross Profit 93,626 19,000

Costs and expenses:
General and administrative 455,999 1,111,000
Research and development 730,774 637,000
------------------------ -------------------------

Total costs and expenses 1,186,773 1,748,000
------------------------ -------------------------

Loss from operations (1,093,147) (1,729,000)
------------------------ -------------------------

Other expenses (income):
Interest expense - 13,000
Gain on sale of asset (2,142) -
------------------------ -------------------------

Total other expense (2,142) 13,000
------------------------ -------------------------

NET LOSS $ (1,091,005) $ (1,742,000)
======================== =========================

Weighted average number of common shares
outstanding-basic & diluted 18,257,808 16,899,376
======================== =========================

Basic and diluted loss per common share $ (0.06) $ (0.10)
======================== =========================

The accompanying notes are an integral part of the
consolidated financial statements

F-4

ENVIRO VORAXIAL TECHNOLOGY, INC. AND SUBSIDIARY

CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' DEFICIENCY

Common Stock Additional
------------------------- Paid-in Deferred Accumulated
Shares Amount Capital Compensation Deficit Total
------------ ---------- ------------- ------------- ------------- -----------

Balance at December 31, 2003 15,502,636 $ 15,000 $ 2,725,000 $ (21,000) $ (3,049,000) $ (330,000)

Issuance of units consisting
of common stock and warrants
net of issuance costs 1,935,000 2,000 1,283,000 1,285,000
Common stock and warrants
issued in private placement 61,666 - 37,000 37,000
Issuance of options for accrued
compensation 747,000 747,000
Issuance of options for services 18,000 18,000
Amortization of deferred compensation 148,000 148,000
Common stock issued for service 177,100 1,000 143,000 (138,000) 6,000

Net Loss - - - - (1,742,000) (1,742,000)
----------- ---------- ------------- ------------ ------------- -----------

Balance at December 31, 2004 17,676,402 $ 18,000 $ 4,953,000 $ (11,000) $ (4,791,000) $ 169,000

Issuance of common stock for consulting
services 300,000 300 141,519 (56,875) - 84,944
Issuance of options for services - - 21,000 - 21,000
Issuance of restricted common stock at
$.40 per share 1,468,333 1,144 586,189 - - 587,333
Issuance of common stock for consulting
services 15,000 15 7,635 - - 7,650
Amortization of deferred compensation - - - 14,438 - 14,438
Net Loss - - - - (1,091,005) (1,091,005)
----------- ---------- ------------- ------------ ------------- -----------

Balance - December 31, 2005 19,459,735 $ 19,459 $ 5,709,343 $ (53,437) $ (5,882,005) $ (206,640)
=========== ========== ============= ============ ============= ===========

The accompanying notes are an integral part of the
consolidated financial statements

F-5

ENVIRO VORAXIAL TECHNOLOGY, INC. AND SUBSIDIARY
CONSOLIDATED STATEMENTS OF CASH FLOWS

For the Years Ended December 31,
---------------------------------
2005 2004
-------------- --------------

Cash Flows From Operating Activities:
Net loss $ (1,091,005) $ (1,742,000)
Adjustments to reconcile net loss to net
cash used by operating activities:
Depreciation 2,720 11,000
Additional compensation for options issued
in excess of accrued compensation - 377,000
Common stock issued for services 149,469 6,000
Amortization of deferred compensation - 148,000
Options issued for consulting services - 18,000
Deferred compensation (42,437) -
Gain on sale of equipment (2,142)
Issuance of warrants for services 21,000
Changes in assets and liabilities:
Accounts receivable - 10,000
Inventory (47,034) (9,000)
Prepaid insurance 3,000 (3,000)
Accounts payable and accrued expenses 255,617 (62,000)
Deposits from customers (10,000) 10,000
-------------- -------------

Net cash used in operating activities (760,812) (1,236,000)
-------------- -------------

Cash Flows From Investing Activities:
Purchase of equipment (5,830) -
Sale of equipment 35,000 -
-------------- -------------

Net cash provided by investing activities 29,170 -
-------------- -------------

Cash Flows From Financing Activities:
Proceeds from sales of common stock 587,333 1,322,000
Repayments of obligation under capital leases - (15,000)
-------------- -------------

Net cash provided by financing activities 587,333 1,307,000
-------------- -------------

Net increase (decrease) in cash and cash equivalents (144,309) 71,000

Cash and cash equivalents, beginning of period 221,000 150,000
-------------- -------------

Cash and cash equivalents, end of period $ 76,691 $ 221,000
============== =============

Supplemental Disclosures

Cash paid during the year for interest $ - $ 13,000
============== =============
Cash paid during the year for taxes $ - $ -
============== =============
Stock options issued to settle accrued compensation $ - $ 370,000
============== =============
Common stock issued for deferred consulting $ 53,437 $ 10,000
============== =============
Common stock issued for conversion of
convertible notes payable $ - $ 250,000
============== =============
Common stock issued for consulting services $ 146,469 $ 6,000
============== =============

The accompanying notes are an integral part of the
consolidated financial statements

F-6

ENVIRO VORAXIAL TECHNOLOGY, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2005 AND 2004

NOTE A - ORGANIZATION AND OPERATIONS

Organization
------------
Enviro Voraxial Technology, Inc. (the "Company") is a provider of environmental
and industrial separation technology. The Company has developed and patented the
Voraxial(R) Separator, which is a technology that efficiently separates solids
and liquids with distinct specific gravities. Potential commercial applications
and markets include oil exploration and production, pre-treatment of wastewater
at municipal wastewater (headworks) facilities, oil and water separation, and
environmental cleanup.

Since 1999, the Company has been focusing its efforts on developing and
marketing the Voraxial(R) Separator. The Company currently operates within two
segments: the sales and marketing of the Voraxial(R) Separator and the
manufacture of the Voraxial(R) Separator.

Florida Precision Aerospace, Inc. (FPA) is the wholly-owned subsidiary of the
Company and is used to do contract work with the aerospace, automotive and
defense contracting activity.

NOTE B - GOING CONCERN

The Company has experienced net losses, has negative cash flows from operating
activities, and has to raise capital to sustain operations. There is no
assurance that the Company's developmental and marketing efforts will be
successful, that the Company will ever have commercially accepted products, or
that the Company will achieve a level of revenue sufficient to provide cash
inflows to sustain operations. The Company will continue to require the infusion
of capital until operations become profitable. During 2005, the Company
anticipates seeking additional capital, increasing sales of the Voraxial(R)
Separator and continuing to restrict expenditures. As a result of the above, the
accompanying consolidated financial statements have been prepared assuming that
the Company will continue as a going concern. The consolidated financial
statements do not include any adjustments that might result from the outcome of
this uncertainty.

NOTE C - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Principles of Consolidation
---------------------------
The consolidated financial statements include the accounts of the parent
company, Enviro Voraxial Technology, Inc., and its wholly-owned subsidiary,
Florida Precision Aerospace, Inc. All significant intercompany accounts and
transactions have been eliminated.

Estimates
---------
The preparation of consolidated financial statements in conformity with
accounting principles generally accepted in the United States of America
requires management to make estimates and assumptions that affect the reported
amounts of assets and liabilities and disclosures of contingent assets and

F-7

ENVIRO VORAXIAL TECHNOLOGY, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2005 AND 2004

liabilities at the date of the financial statements and the reported amounts of
revenue and expenses during the reporting period. Actual results may differ.

Revenue Recognition
-------------------
The Company presents revenue in accordance with Staff Accounting Bulletin (SAB)
No. 104 "Revenue Recognition in Financial Statements". Under SAB 104, revenue is
realized when persuasive evidence of an arrangement exists, delivery has
occurred, the price is fixed or determinable and collectibility is reasonably
assured.

In accordance with the above, the Company recognizes revenue from rental of
equipment, based on the terms of the agreement. Revenues from contracts are
recognized upon customer acceptance of shipment.

Fair Value of Instruments
-------------------------
The carrying amounts of the Company's financial instruments, including cash and
cash equivalents, inventory, accounts payable and accrued expenses at December
31, 2005, approximate their fair value because of their relatively short-term
nature.

Cash and Cash Equivalents
-------------------------
The Company considers all highly liquid investments with a maturity of three
months or less at the date of purchase to be cash equivalents. The Company
maintains its cash balances with various financial institutions. Balances at
these institutions may at times exceed the Federal Deposit Insurance Corporate
limits.

Inventory
---------
Inventory consists of components for the Voraxial(R) Separator and is priced at
lower of first-in, first-out cost or market. Inventory includes components held
by third parties in connection with pilot programs as part of the continuing
evaluation by such third parties as to the effectiveness and usefulness of the
service to be incorporated into their respective operations.

Fixed Assets
------------
Fixed assets are stated at cost less accumulated depreciation. The cost of
maintenance and repairs is expensed to operations as incurred. Depreciation is
computed by the straight-line method over the estimated economic useful life of
the assets (5-10 years). Gains and losses recognized from the sales or disposal
of assets is the difference between the sales price and the recorded cost less
accumulated depreciation less costs of disposal.

Net Loss Per Share
------------------
Basic and diluted loss per share has been computed by dividing the net loss
available to common stockholders by the weighted average number of common shares
outstanding. The warrants and stock options have been excluded from the
calculation since they would be anti-dilutive.

F-8

ENVIRO VORAXIAL TECHNOLOGY, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2005 AND 2004

Such equity instruments may have a dilutive effect in the future and include the
following potential common shares:

Warrants 5,589,367
Stock options 3,729,666
----------
9,319,033
==========
Income Taxes
------------
Deferred income taxes are recognized for the tax consequences in future years of
differences between the tax bases of assets and liabilities and their financial
reporting amounts based on enacted tax laws and statutory tax rates applicable
to the periods in which the differences are expected to affect taxable income.
Valuation allowances are established when necessary to reduce deferred tax
assets to the amount expected to be realized.

Research and Development Expenses
---------------------------------
Research and development costs, which consist of travel expenses, consulting
fees, subcontractors and salaries are expensed as incurred.

Advertising Costs
-----------------
Advertising costs are expensed as incurred and are included in general and
administrative expenses. Amounts incurred for advertising as of December 31,
2005 and 2004 were $10,121 and $15,000, respectively.

Stock-Based Compensation
------------------------
The Company accounts for stock-based employee compensation under Accounting
Principles Board (APB) Opinion No. 25, "Accounting for Stock Issued to
Employees," and related interpretations. The Company has adopted the
disclosure-only provisions of Statement of Financial Accounting Standards (SFAS)
No. 123, "Accounting for Stock-Based Compensation," and SFAS No. 148,
"Accounting for Stock-Based Compensation - Transition and Disclosure," which was
released in December 2002 as an amendment of SFAS No. 123. The Company currently
accounts for stock-based compensation under the fair value method using the
Black-Scholes option pricing model as indicated in Note G.

Accounting for the Impairment of Long-Lived Assets
--------------------------------------------------

The long-lived assets held and used by the Company are reviewed for impairment
whenever events or changes in circumstances indicate that the carrying amount of
assets may not be recoverable. It is reasonably possible that these assets could
become impaired as a result of technology or other industry changes.
Determination of recoverability of assets to be held and used is by comparing
the carrying amount of an asset to future net undiscounted cash flows to be
generated by the assets. If such assets are considered to be impaired, the
impairment to be recognized is measured by the amount by which the carrying

F-9

ENVIRO VORAXIAL TECHNOLOGY, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2005 AND 2004

amount of assets exceeds the fair value of the assets. Assets to be disposed of
are reported at the lower of the carrying amount or fair value less costs to
sell. There were no impairments of long-lived assets in 2005 and 2004.

Recent Accounting Pronouncements
--------------------------------

Share-Based Payment

In December 2004, the FASB issued a revision of SFAS 123 (SFAS 123(R)) that
requires compensation costs related to share-based payment transactions to be
recognized in the statement of operations. With limited exceptions, the amount
of compensation cost will be measured based on the grant-date fair value of the
equity or liability instruments issued. In addition, liability awards will be
re-measured each reporting period. Compensation cost will be recognized over the
period that an employee provides service in exchange for the award. SFAS 123(R)
replaces SFAS 123 and is effective as of February 1, 2006. Based on zero shares
and awards outstanding as of January 31, 2006, the adoption of SFAS 123(R) would
have no impact on earnings for the fiscal year.

In March 2005, the U.S. Securities and Exchange Commission, or SEC, released
Staff Accounting Bulletin (SAB) 107, "Share-Based Payments". The interpretations
in SAB 107 express views of the SEC staff, or staff, regarding the interaction
between SFAS 123R and certain SEC rules and regulations, and provide the staff's
views regarding the valuation of share-based payment arrangements for public
companies. In particular, SAB 107 provides guidance related to share-based
payment transactions with non-employees, the transition from nonpublic to public
entity status, valuation methods (including assumptions such as expected
volatility and expected term), the accounting for certain redeemable financial
instruments issued under share-based payment arrangements, the classification of
compensation expense, non-GAAP financial measures, first-time adoption of SFAS
123R in an interim period, capitalization of compensation cost related to
share-based payment arrangements, the accounting for income tax effects of
share-based payment arrangements upon adoption of SFAS 123R, the modification of
employee share options prior to adoption of SFAS 123R and disclosures in
Management's Discussion and Analysis subsequent to adoption of SFAS 123R. SAB
107 requires stock-based compensation be classified in the same expense lines as
cash compensation is reported for the same employees. The Company and management
is reviewing SAB 107 in conjunction with its review of SFAS 123R.

Non-monetary Exchange

In December 2004, the FASB issued SFAS No. 153, "Exchanges of Non-monetary
Assets--An Amendment of Accounting Principles Board (APB) Opinion No. 29,
Accounting for Non-monetary Transactions" ("SFAS 153"). SFAS 153 eliminates the
exception from fair measurement for non-monetary exchanges of similar productive
assets in paragraph 21(b) of APB Opinion No. 29, "Accounting for Non-monetary
Transactions," and replaces it with an exception for exchanges that do not have

F-10

ENVIRO VORAXIAL TECHNOLOGY, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2005 AND 2004

commercial substance. SFAS 153 specifies that a non-monetary exchange has
commercial substance if the future cash flows of the entity expected to change
significantly as a result of the exchange. SFAS 153 is effective for fiscal
periods beginning after June 15, 2005. The adoption of SFAS 153 is not expected
to have a material impact on the Company's current financial condition or
results of operations.

Conditional Asset Retirement

In March 2005, the FASB issued FASB Interpretation (FIN) No. 47 - "Accounting
for Conditional Asset Retirement Obligations - an Interpretation of SFAS 143
(FIN No. 47). FIN No. 47 clarifies the timing of liability recognition for legal
obligations associated with the retirement of a tangible long-lived asset when
the timing and/or method of settlement are conditional on a future event. FIN
No. 47 is effective no later than December 31, 2005. FIN No. 47 did not impact
the Company for the year ended January 31, 2006.

Accounting Changes and Error Corrections

In May 2005, the FASB issued SFAS No. 154, "Accounting Changes and Error
Corrections, a Replacement of APB No. 20 and FASB 3". SFAS No. 154 requires
retrospective application to prior periods' financial statements of a voluntary
change in accounting principle unless it is impracticable. APB Opinion No. 20
"Accounting Changes," previously required that most voluntary changes in
accounting principle be recognized by including in net income of the period of
the change the cumulative effect of changing to the new accounting principle.

NOTE D - CONCENTRATION OF CREDIT RISK

One customer accounted for approximately 80% of revenue for the years end
December 31, 2005 and 2004. There were no outstanding receivables from this
customer for either year.

NOTE E - FIXED ASSETS

Fixed assets as of December 31, 2005 consists of:

2005
-------------
Machinery and equipment $ 278,929
Furniture and fixtures 14,498
-------------
Total 293,427
Less: accumulated depreciation (288,089)
-------------
Fixed Assets, net $ 5,338
-------------

F-11

ENVIRO VORAXIAL TECHNOLOGY, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2005 AND 2004

Depreciation expense for the years ended December 31, 2005 and 2004 amounted to
$2,720 and $11,000 respectively.

NOTE F - RELATED PARTY TRANSACTIONS

For the years ended December 31, 2005 and 2004, the Company incurred consulting
expenses from the chief executive officer and majority stockholder of the
Company of $165,000 each year. Of these amounts, approximately $43,000 and
$25,000 have been paid out for the years ended December 31, 2005 and 2004,
respectively. The unpaid balance has been included in accrued expenses.

NOTE G - CAPITAL TRANSACTIONS

Common stock
------------
On January 15, 2004, the Company issued options to purchase an aggregate of
1,394,666 shares of common stock to the Company's chief executive officer, one
employee and one consultant, in consideration for such individuals accrued
compensation in the aggregate amount of $370,000. Options to purchase 697,333
shares of our common stock are exercisable at $0.60 and options to purchase
697,333 shares of our common stock are exercisable at $1.00. The options are
exercisable for a period of five years commencing January 15, 2004. The Company
estimated the fair value of the stock options at the grant date by using the
Black-Scholes option-pricing model, with the following weighted average
assumptions: no dividend yield for all years, expected volatility of 80%,
risk-free interest rate of 4% and an expected life of 5 years, resulting in a
fair value of $747,000, and additional compensation expense of $370,000.

In January 2004, the Company issued 170,000 shares of common stock to a
consultant valued at $138,000 based on the closing market price of the Company's
common stock on the date of the agreement. This amount is being amortized over
the one year life of the consulting agreement, resulting in consulting expense
of $127,000 in 2004. The remaining unamortized balance of $11,000 has been
expensed in 2005.

In January 2004, the Company closed a private placement which commenced in 2003.
Under the private placement the Company sold an aggregate of 61,666 shares of
restricted common stock at $0.60 per share plus warrants to purchase 61,666
shares of common stock at an exercise price of $1.00 per share to four investors
for proceeds of $37,000 during the three months ended June 30, 2004. The
warrants are exercisable for a period of five years from the date of closing.

On February 18, 2004, the Company issued options to purchase an aggregate of
30,000 shares of common stock exercisable at $0.71 per share to three
individuals as consideration for joining the Company's advisory committee. The
options were initially exercisable until February 18, 2006, but have been
extended to February 18, 2007. The Company calculated estimate of the fair value

F-12

ENVIRO VORAXIAL TECHNOLOGY, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2005 AND 2004

of the stock options at the grant date by using the Black-Scholes option-pricing
model, with the following weighted average assumptions: no dividend yield for
all years, expected volatility of 80%, risk-free interest rate of 4% and an
expected life of 3 years, resulting in a fair value of $18,000. This amount was
expensed in 2004.

In February 2004, the Company extended the exercisable life of certain warrants
issued to investors to purchase an aggregate of 243,200 shares of common stock
issued in 2000 for a period of one year. The warrants now expire in February
2006.

In February 2004, the Company extended the exercisable life of certain warrants
issued to investors to purchase an aggregate of 200,000 shares of common stock
issued in 2001 for a period of one year. The warrants now expire in April 2006.

During January and February 2004, the Company issued convertible notes to three
individuals in the aggregate amount of $250,000 through a convertible note
agreement whereby the notes automatically convert into securities of the Company
pursuant to the terms of a private placement initiated in March 2004. Effective
May 5, 2004, the notes converted into 250,000 shares.

From May 2004 through August 2004, the Company sold an aggregate of 1,935,000
units of securities to 41 investors for gross proceeds of $1,451,000 under the
private placement. The Company has paid a placement agent a commission of 10% of
the gross proceeds and a non-accountable expense allowance of 3% of the gross
proceeds and issued the placement agent warrants to purchase six shares of
common stock (three shares at $0.75 and three shares at $1.00) for each 20 units
sold in the offering. Each unit consisted of one share of restricted common
stock at $0.75 per share and one warrant to purchase one share of common stock
at $1.00 per share. The warrants are exercisable for a period of five years from
the date of closing.

On June 30, 2004, the Company issued 7,100 shares of our common stock to an
individual in consideration for services rendered. The number of shares issued
was based on the fair value of the consulting services. The Company has expensed
$6,000 in 2004.

In July 2004, the Company issued 100,000 shares of common stock, pertaining to a
2001 offering that were recorded as stock to be issued at December 31, 2003.

In January 2005, the Company entered into a one-year consulting agreement with
its former Chief Operating Officer for engineering design, marketing and sales
of Company products and services. Pursuant to this agreement, the Company
granted 50,000 warrants to this individual exercisable at $1.00 per share. These
warrants vest equally in 12 traunches over a period of one year commencing in
January, 2005 and expire in January 2008. The Company calculated the fair value
of the warrants at the grant date by using the Black-Scholes option-pricing
model with the following weighted average assumptions: no dividend yield for all
the years; expected volatility of 133%; risk-free interest rate of 3% and an
expected life of 3 years, resulting in a fair value of approximately $21,000.

F-13

ENVIRO VORAXIAL TECHNOLOGY, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2005 AND 2004

In May 2005, the Company issued 75,000 shares of common stock to a consultant,
valued at $57,000, which is based on the closing market price of the Company's
common stock on the date of the agreement. In addition, the Company paid $40,000
in cash to the consultant, which has been amortized over the life of the
consulting agreement of four months. During November 2005, the Company issued an
additional 225,000 shares per the terms of the agreement. These shares were
valued at $85,500, which is based on the closing market price of the Company's
common stock on the date of the agreement.

During 2005, the Company issued 1,468,333 shares of restricted common stock at
$.40 per share, with total proceeds of $587,333 being received.

In July 2005, the Company entered into a consulting agreement. The terms of
agreement included issuance of 15,000 shares of common stock for services
rendered. The number of shares issued was based on the fair value of the
consulting services of $7,650.

Options
-------
Information with respect to employee stock options outstanding and employee
stock options exercisable at December 31, 2005 is as follows:

Weighted Average
Options Vested Exercise Price Per Exercise Price Per
Oustanding Shares Common Share Option Oustanding
---------- --------- ------------------ -----------------

Balance, December 31, 2002 2,245,000 1,115,000 $0.15-$0.77 $0.21
Granted/vested during the year 10,000 1,120,000 $1.00

Balance, December 31, 2002 2,245,000 2,235,000 $0.15-$1.00 $0.21
Granted/vested during the year 1,424,666 1,424,666 $0.15-$1.00 $0.79

Balance, December 31, 2004 3,679,666 3,659,666 $0.15-$1.00 $0.52

Granted/vested during the year 50,000 50,000 $1.00
Balance, December 31, 2005 3,729,666 3,709,666 $0.15-$1.00 $0.52

The following table summarizes information about the stock options outstanding
at December 31, 2005

Number Weighted Weighted
Oustanding at Average Average
Exercise December 31, Remaining Exercise Number Excercisable Weighted Average
Price 2005 Contractual Life Price at December 31, 2005 Exercise Price
----- ---- ---------------- ----- -------------------- --------------

0.30 45,000 0.87 0.30 45,000 0.30
0.77 200,000 1.13 0.77 200,000 0.77
0.15 2,000,000 1.55 0.15 2,000,000 0.15
1.00 10,000 1.00 1.00 10,000 1.00
0.60 697,333 3.13 0.60 697,333 0.60
1.00 697,333 3.13 1.00 697,333 1.00
1.00 50,000 3.00 1.00 50,000 1.00
0.71 30,000 1.17 0.71 30,000 0.71
--------- ---------
3,729,666 3,729,666

F-14

ENVIRO VORAXIAL TECHNOLOGY, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2005 AND 2004

Warrants
--------

Number Range of Exercise Number
Outstanding Price Exercisable
----------- ----- -----------

Balance - December 31, 2002 1,477,200 $1.00 - $9.00 1,477,200
Issued 1,585,002 $1.00 1,385,002
--------- ---------

Balance, December 31, 2003 3,062,202 $1.00 - $9.00 2,862,202
Issued 2,527,165 $0.75 - $1.00 2,527,165
--------- ---------

Balance, December 31, 2004 5,589,367 $0.75 - $9.00 5,389,367
Issued

Balance, December 31, 2005 5,589,367 $0.75 - $9.00 5,389,367
--------- ---------

NOTE H - INCOME TAXES

Deferred income taxes arise from timing differences resulting from income and
expense items reported for financial accounting and tax purposes in different
periods. A deferred tax asset valuation allowance is recorded when it is more
likely than not that deferred tax assets will not be realized. There are no
deferred taxes for the year ended December 31, 2005.

There was no income tax expense for the year ended December 31, 2005 due to the
Company's net losses. Due to an estimated net operating loss carry-forward of
approximately $5,885,000 available to offset future taxable income through 2019
and recoverability is not certain, there is no expected tax benefit calculated.

NOTE I - COMMITMENTS AND CONTINGENCIES

Employment Agreements
---------------------
The Company entered into an employment agreement dated January 17, 2002 with an
individual to serve as the Vice President and Director of Business Development.
The agreement provides for a contingent bonus to be paid to this employee in the
amount of $300,000 to improve the financial condition of the Company. Such bonus
is payable upon the Company obtaining a total of $3 million of financing or when
revenue exceeds $1 million. In 2002, this individual was granted stock options
to purchase 2 million shares of common stock with an exercise price of $0.15 per
share. The market price at the date of grant was $0.12 per share.

The Company hired two employees under employment agreements that commenced in
January 2003. The combined salaries for 2003 are $215,000 subject to annual
increases beginning in 2004. Both agreements have a term of 5 years. One
agreement provided for the granting of up to 300,000 cashless exercise warrants
to purchase common stock at $1 per share which may result in a significant
charge to operations in the future. This agreement was terminated by mutual
agreement on December 31, 2004, and only 150,000 warrants were vested and are

F-15

ENVIRO VORAXIAL TECHNOLOGY, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2005 AND 2004

exercisable. The other agreement provides for the granting of 10,000 stock
options to purchase common stock at $1 per share exercisable ratably over two
years from the date of grant.

Operating Lease
---------------
The Company leases office and warehouse space in Ft. Lauderdale, Florida under a
business lease agreement for a three-year term ending in August 2007. Minimum
future lease payments for the next two years are as follows:

Years ending December 31,
-------------------------

2006 $ 63,700
2007 42,467
----------
106,167
----------

Rent expense charged to operations amounted to $62,000 and $60,000 in 2005 and
2004, respectively.

NOTE J - SUBSEQUENT EVENTS

In March 2006, a Voraxial(R) 4000 Separator was sold to ConocoPhillips for
produced water separation. The machine will be used to enhance the handling of
large volumes of produced water and water injection on at a production facility.

F-16

ENVIRO VORAXIAL TECHNOLOGY, INC. AND SUBSIDIARY
CONSOLIDATED FINANCIAL INFORMATION
SEPTMBER 30, 2006 and 2005

Table of Contents

Page
----

Condensed Consolidated Balance Sheet - September 30, 2006 (Unaudited).................... F-18

Condensed Consolidated Statements of Operations for the Three
Months and Nine Months Ended September 30, 2006 and 2005 (Unaudited).................. F-19

Condensed Consolidated Statements of Cash Flows for the
Nine Months Ended September 30, 2006 and 2005 (Unaudited)............................. F-20

Notes to Condensed Consolidated Financial Statements (Unaudited)......................... F-21

F-17

ENVIRO VORAXIAL TECHNOLOGY, INC. AND SUBSIDIARY
CONDENSED CONSOLIDATED BALANCE SHEET

30-Sep
2006
----------------
(Unaudited)

ASSETS

CURRENT ASSETS:
Cash and cash equivalents $ 381,492
Accounts receivable 41,430
Inventory 197,132
Prepaid expenses 8,997
---------------

Total current assets 629,051

FIXED ASSETS, NET 4,897

OTHER ASSETS 10,000
---------------

Total assets $ 643,948
===============

LIABILITIES AND SHAREHOLDERS' DEFICIT

CURRENT LIABILITIES:
Accounts payable and accrued expenses $ 589,515
---------------

Total current liabilities 589,515
---------------

Total liabilities 589,515
---------------

COMMITMENTS AND CONTINGENCIES

SHAREHOLDERS' DEFICIT:
Common stock, $.001 par value, 42,750,000 shares authorized
21,492,235 shares issued and oustanding 21,492
Additional paid-in capital 6,520,330
Deferred consulting (20,000)
Accumulated deficit (6,467,389)
---------------

Total shareholders' deficit 54,433
---------------

Total liabilities and shareholders' deficit $ 643,948
===============

The accompanying notes are an integral part of the consolidated financial
statements.

F-18

ENVIRO VORAXIAL TECHNOLOGY, INC. AND SUBSIDIARY
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

Three Months Ended September 30, Nine Months Ended September 30,
-------------------------------------- -------------------------------------
2006 2005 2006 2005
----------------- ------------------ ----------------- -----------------
(Unaudited) (Unaudited) (Unaudited) (Unaudited)

Revenues, net $ 46,261 $ 8,000 $ 208,425 $ 128,000

Cost of goods sold 6,423 - 71,410 34,000
---------------- ----------------- ---------------- ----------------

Gross Profit 39,838 8,000 $ 137,015 94,000

Costs and expenses:
General and administrative 135,748 106,000 441,257 359,000
Research and development 102,408 260,000 281,124 588,000
---------------- ----------------- ---------------- ----------------

Total costs and expenses 238,156 366,000 722,381 947,000
---------------- ----------------- ---------------- ----------------

Loss from operations (198,318) (358,000) $ (585,366) (853,000)
---------------- ----------------- ---------------- ----------------

Other income
Gain on sale of equipment - - - 2,000
---------------- ----------------- ---------------- ----------------
Total other income - - - 2,000
---------------- ----------------- ---------------- ----------------

NET LOSS $ (198,318) $ (358,000) $ (585,366) $ (851,000)
================ ================= ================ ================

Weighted average number of common shares
outstanding-basic & diluted 20,751,262 18,279,323 20,067,888 18,291,356
================ ================= ================ ================

Basic and diluted loss per common share $ (0.01) $ (0.02) $ (0.03) $ (0.05)
================ ================= ================ ================

The accompanying notes are an integral part of the consolidated financial
statements.
F-19

ENVIRO VORAXIAL TECHNOLOGY, INC. AND SUBSIDIARY
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

For the Nine Months Ended September 30,
-----------------------------------------------
2006 2005
---------------------- ----------------------
(Unaudited) (Unaudited)

Cash Flows From Operating Activities:
Net loss $ (585,384) $ (851,000)
Adjustments to reconcile net loss to net
cash used by operating activities:
Depreciation 531 3,000
Gain on sale of equipment - (2,000)
Common stock issued for services 60,000 -
Amortization of deferred compensation 33,367 84,000
Deferred compensation 20,000 -
Changes in assets and liabilities:
Accounts receivable (41,430) -
Inventory (71,098) (47,000)
Prepaid insurance (8,997) (5,000)
Accounts payable and accrued expenses 164,812 214,000
Deposits from customers - (7,000)
--------------------- ---------------------

Net cash used in operating activities (428,199) (611,000)
--------------------- ---------------------

Cash Flows From Investing Activities:
Purchase of equipment - (6,000)
Proceeds from sale of equipment, net - 35,000
--------------------- ---------------------

Net cash provided by investing activities - 29,000
--------------------- ---------------------

Cash Flows From Financing Activities:
Proceeds from sales of common stock 733,000 487,000
--------------------- ---------------------

Net cash provided by financing activities 733,000 487,000
--------------------- ---------------------

Net increase in cash and cash equivalents 304,801 (95,000)

Cash and cash equivalents, beginning of period 76,691 221,000
--------------------- ---------------------

Cash and cash equivalents, end of period $ 381,492 $ 126,000
===================== =====================

Supplemental Disclosures

Cash paid during the year for interest $ - $ -
===================== =====================
Cash paid during the year for taxes $ - $ -
===================== =====================
Common stock issued for deferred consulting $ 20,000 $ -
===================== =====================
Common stock issued for consulting services $ 60,000 $ 57,000
===================== =====================
Warrants issued for services $ - $ 21,000
===================== =====================

The accompanying notes are an integral part of the consolidated financial
statements.

F-20

NOTE A - ORGANIZATION AND OPERATIONS

Organization
------------

Enviro Voraxial Technology, Inc. (the "Company") is a provider of environmental
and industrial separation technology. The Company has developed and patented the
Voraxial(R) Separator, which is a technology that efficiently separates solids
and liquids with distinct specific gravities. Potential commercial applications
and markets include oil exploration and production, oil and water separation,
environmental cleanup and pre-treatment of wastewater at municipal wastewater
(headworks) facilities.

Florida Precision Aerospace, Inc. (FPA) is the wholly owned subsidiary of the
Company and is used to do contract work with the aerospace, automotive and
defense contracting activity.

In September 2006, the Company received an order to supply Transocean Inc.
semisubmersible rig Sedco 702 with a Voraxial 2000 Offshore Deck Water Drainage
System. The System will be utilized to handle and separate contaminated drill
floor run-off water containing solids and drilling fluids.

NOTE B - GOING CONCERN

The Company has experienced net losses and negative cash flows from operating
activities. They will need to raise capital to sustain operations. There is no
assurance that the Company will ever have commercially accepted products, that
their developmental and marketing efforts will be successful or that they will
achieve a level of revenue sufficient to provide cash inflows to sustain
operations. The Company will continue to require the infusion of capital until
operations become profitable. During 2006, the Company anticipates seeking
additional capital, increasing sales of the Voraxial(R) Separator and continuing
to restrict expenditures. As a result of the above, the accompanying
consolidated financial statements have been prepared assuming that the Company
will continue as a going concern. The consolidated financial statements do not
include any adjustments that might result from the outcome of this uncertainty.

NOTE C - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Interim Financial Statements
----------------------------

The interim financial statements presented herein have been prepared pursuant to
the rules and regulations of the Securities and Exchange Commission ("SEC").
Certain information and footnote disclosures normally included in financial
statements prepared in accordance with accounting principles generally accepted
in the United States of America have been condensed or omitted pursuant to such
rules and regulations. The interim financial statements should be read in
conjunction with the Company's annual financial statements, notes and accounting
policies included in the Company's annual report on Form 10-KSB for the year
ended December 31, 2005 as filed with the SEC. In the opinion of management, all
adjustments (consisting only of normal recurring adjustments) which are
necessary to provide a fair presentation of financial position as of September
30, 2006 and the related operating results and cash flows for the interim period
presented have been made. The results of operations, for the period presented
are not necessarily indicative of the results to be expected for the year.

F-21

NOTE D - CAPITAL TRANSACTIONS

Common stock
------------

In January 2006, the Company extended the exercisable life of certain warrants
issued to investors to purchase an aggregate of 243,200 shares of common stock
issued in 2000 for a period of one year. The warrants now expire in February
2007.

In January 2006, the Company extended the exercisable life of certain warrants
issued to investors to purchase an aggregate of 200,000 shares of common stock
issued in 2001 for a period of one year. The warrants now expire in April 2007.

During the six months ended June 30, 2006 the Company sold 720,000 shares of
common stock for $0.40 per share in a private placement offering. Total proceeds
from the sale were $288,000.

During the three months ended September 30, 2006 the Company sold 1,112,500
shares of common stock for $.40 per share in a private placement offering. Total
proceeds from the sale were $445,000.

Options
-------

Information with respect to employee stock options outstanding and employee
stock options exercisable at September 30, 2006 is as follows:

Weighted Average
Exercise Price Exercise Price
Options Vested Per Per Option
Outstanding Shares Common Share Outstanding
----------------- ----------------- ----------------- -------------------

Balance, December 31, 2005 3,729,666 3,709,666 $0.15-$1.00 $0.52

Granted/vested during the quarter - - - -

Balance, March 31, 2006 3,729,666 3,709,666 $0.15-$1.00 $0.52

Granted/vested during the quarter - - - -

Balance, September 30, 2006 3,729,666 3,709,666 $0.15-$1.00 $0.52

F-22

The following table summarizes information about the stock options outstanding
at September 30, 2006:

Weighted
Number Average
Outstanding at Remaining Weighted Number Exercisable
Exercise September 30, Contractual Average at September 30, Weighted Average
Price 2006 Life Exercise Price 2006 Exercise Price
-------------------- ----------------- ---------------- ----------------- --------------------- ------------------

0.30 45,000 0.87 0.30 45,000 0.30

0.77 200,000 1.13 0.77 200,000 0.77

0.15 2,000,000 1.55 0.15 2,000,000 0.15

1.00 10,000 1.00 1.00 10,000 1.00

0.60 697,333 3.13 0.60 697,333 0.60

1.00 697,333 3.13 1.00 697,333 1.00

1.00 50,000 3.00 1.00 50,000 1.00

0.71 30,000 1.17 0.71 30,000 0.71
--------- ---------
3,729,666 3,729,666
--------- ---------

Warrants
--------

Information with respect to warrants outstanding and exercisable at September
30, 2006 is as follows:

Number Range of Exercise Number
Outstanding Price Exercisable
---------------- --------------------- -------------------

Balance, December 31, 2005 5,589,367 $0.75 - $9.00 5,389,367

Issued

Balance, March 31, 2006 5,589,367 $0.75 - $9.00 5,389,367

Issued
--------- ---------
Balance, September 30, 2006 5,589,367 $0.75 - $9.00 5,389,367
--------- ---------

NOTE E - CONCENTRATION

Revenues
--------

For the nine months ended September 30, 2006, the Company generated over 80% of
its revenues from one customer.

F-23

YOU SHOULD RELY ONLY ON THE INFORMATION CONTAINED IN THIS DOCUMENT OR THAT WE
HAVE REFERRED YOU TO. WE HAVE NOT AUTHORIZED ANYONE TO PROVIDE YOU WITH
INFORMATION THAT IS DIFFERENT. THIS PROSPECTUS DOES NOT CONSTITUTE AN OFFER OF
ANY SECURITIES OTHER THAN THOSE TO WHICH IT RELATES OR AN OFFER TO SELL, OR A
SOLICITATION OF ANY OFFER TO BUY, TO ANY PERSON IN ANY JURISDICTION WHERE SUCH
AN OFFER OR SOLICITATION WOULD BE UNLAWFUL. NEITHER THE DELIVERY OF THIS
PROSPECTUS NOR ANY SALE MADE HEREUNDER SHALL, UNDER ANY CIRCUMSTANCES, CREATE AN
IMPLICATION THAT THE INFORMATION SET FORTH HEREIN IS CORRECT AS OF ANY TIME
SUBSEQUENT TO THE DATE HEREOF.

TABLE OF CONTENTS

Page
----

Prospectus Summary........................................................................................... 1
Forward-Looking Statements................................................................................... 4
Risk Factors................................................................................................. 4
Capitalization............................................................................................... 9
Price Range of common stock and Dividend Policy.............................................................. 10
Use of Proceeds.............................................................................................. 11
Management's Discussion and Analysis or Plan of Operation.................................................... 12
Business..................................................................................................... 17
Management................................................................................................... 22
Certain Transactions......................................................................................... 25
Principal Shareholders....................................................................................... 26
Description of Securities.................................................................................... 27
Selling Shareholders......................................................................................... 28
Plan of Distribution......................................................................................... 40
Shares Eligible for Future Sale.............................................................................. 41
Legal Matters................................................................................................ 41
Experts...................................................................................................... 41
Additional Information....................................................................................... 41
Financial Statements......................................................................................... F-1

9,543,363 Shares

Enviro Voraxial Technology, Inc.

-------------
PROSPECTUS
-------------

_______________, 2007

PART TWO

INFORMATION NOT REQUIRED IN PROSPECTUS

ITEM 24. INDEMNIFICATION OF DIRECTORS AND OFFICERS

The Idaho Statutes (the "Idaho Statutes") permits the indemnification
of directors, employees, officers and agents of Idaho corporations. Our Articles
of Incorporation (the "Articles") and Bylaws provide that we shall indemnify its
directors and officers to the fullest extent permitted by the Idaho Statutes.

Item 25. Other Expenses of Issuance and Distribution

The estimated expenses payable by us in connection with the
distribution of the securities being registered are as follows:

SEC Registration and Filing Fee............................................................. $ 293.09
Legal Fees and Expenses*.................................................................... 30,000.00
Accounting Fees and Expenses*............................................................... 5,000.00
Financial Printing*......................................................................... 5,000.00
Transfer Agent Fees*........................................................................ 1,000.00
Blue Sky Fees and Expenses*................................................................. 1,000.00
Miscellaneous*.............................................................................. 5,000.00
-------------
TOTAL.................................................................................. $ 47,293.09
=============

------------------
* Estimated

II-1

None of the foregoing expenses are being paid by the selling
shareholders.

ITEM 26. RECENT SALES OF UNREGISTERED SECURITIES

In April 2001, we raised $100,000 through the private placement of our
securities pursuant to Regulation D of the Securities Act. We sold 1,000 units
containing share of our common stock and warrants to 1 investor. Each unit was
comprised of 100 shares of restricted common stock, par value $.001, and 200
common stock purchase warrants, of which 100 warrants are exercisable at $3.00
per share and 100 warrants are exercisable at $4.00 per share. The warrants
expire April 2007. The transaction was exempt from registration under Section
4(2) of the Securities Act.

In July 2001, we raised $20,000 through a private transaction whereby
the Company issued 23,530 shares of restricted common stock at $.85 per share to
an individual investor. The transaction was exempt from registration under
Section 4(2) of the Securities Act.

On January 17, 2002, we issued options to purchase 2,000,000 shares of
our common stock at an exercise price of $.15 per share. The market price at the
date of the grant was $.12 per share. These options were issued pursuant to an
employment agreement. In addition, during year ended December 31, 2002, we also
issued stock options to purchase 200,000 shares of common stock to an additional
employee of our Company. These options have an exercise price of $.77 per share.

On December 31, 2002, we issued 6,000,000 shares of common stock to
Alberto DiBella pursuant to the automatic conversion rights of the preferred
stock held by Mr. DiBella. The 6,000,000 shares of preferred stock held by Mr.
DiBella were returned to treasury and cancelled.

During the year ended December 31, 2002, we sold 5.17 units of
securities at $60,000 per unit in a private placement to 5 investors. Each unit
consisted of 100,000 shares of common stock, 100,000 warrants to purchase
100,000 shares of common stock at an exercise price of $1 per share and 100,000
warrants to purchase 100,000 shares of common stock at an exercise price of
$1.25 per share. The warrants issued at $1 per share are callable at par value
provided the stock trades above $1.50 per share for 20 consecutive trading days.
The warrants issued at $1.25 per share are callable at par value provided the
stock trades above $2 per share for 20 consecutive trading days. Net proceeds
received by our Company aggregated $286,000. The warrants are exercisable from
the date of issuance through December 2007. No warrants have been exercised
through December 31, 2002. The transaction was exempt from registration under
Section 4(2) of the Securities Act.

During the year ended December 2003, we sold an aggregate of 8.08 units
of securities to 30 investors for proceeds of $808,000. Each unit consisted of
166,666 shares of restricted common stock at $0.60 per share and 166,666
warrants to purchase 166,666 shares of common stock at $1.00 per share. The
warrants are exercisable for a period of five years from the date of closing.
The investors received information concerning our company and had the
opportunity to ask questions to the viability of our company. A total of
1,346,665 warrants were issued in this Offering. The issuances were exempt from
registration under Section 4(2) of the Securities Act. The investors received
information concerning the Company and had the opportunity to ask questions
concerning the viability of the Company. The shares contain legends restricting
their transferability absent registration or applicable exemption.

In January 2004, we closed a private placement, which commenced in
2003. Under the private placement we sold an aggregate of 61,666 shares of
II-2

restricted common stock at $0.60 per share and 61,666 warrants to purchase
61,666 shares of common stock at $1.00 per share to four investors for proceeds
of $37,000. The warrants are exercisable for a period of five years from the
date of closing. The transactions were exempt from registration under Section
4(2) of the Securities Act. The investors received information concerning the
Company and had the opportunity to ask questions concerning the viability of the
Company. The shares and warrants contain legends restricting their
transferability absent registration or applicable exemption.

From May 2004 through August 2004, the Company sold an aggregate of
1,935,000 units of securities to 38 accredited investors for gross proceeds of
$1,451,250 under the private placement. The Company has paid Bathgate Capital, a
placement agent, a commission of 10% of the gross proceeds and a non-accountable
expense allowance of 3% of the gross proceeds and issued the placement agent
warrants to purchase six shares of common stock (three shares at $0.75 and three
shares at $1.00) for each 20 units sold in the offering. Each unit consisted of
one share of restricted common stock at $0.75 per share and one warrant to
purchase one share of common stock at $1.00 per share. The warrants are
exercisable for a period of five years from the date of closing. The
transactions were exempt from registration under Regulation D, Rule 506 of the
Securities Act. All of the investors were deemed accredited. The investors
received information concerning the Company and had the opportunity to ask
questions concerning the viability of the Company. The shares and warrants
contain legends restricting their transferability absent registration or
applicable exemption.

On June 30, 2004, we issued 7,100 shares of our common stock to an
individual in consideration for services rendered. The shares were issued
pursuant to the exemption from registration under Section 4(2) of the Securities
Act. The service provider received information concerning the Company and had
the opportunity to ask questions concerning the Company. The shares issued
contain a legend restricting transferability absent registration or applicable
exemption.

During fiscal year 2005, the Company received capital from ten
accredited investors to purchase an aggregate of 1,468,333 shares of the
Company's restricted common stock at $0.40 per share for gross proceeds of
$587,333. The issuances were exempt from registration under Section 4(2) of the
Securities Act. Commissions paid to registered brokers and other expenses
related to the Offering were approximately $50,000. The investors received
information concerning the Company and has the opportunity to ask questions
concerning the viability of the Company. The shares contain legends restricting
their transferability absent registration or applicable exemption.

In May 2005, the Company issued 75,000 shares of common stock to a
consultant valued at $57,000 based on the closing market price of the Company's
common stock on the date of the agreement. In addition, the Company paid $40,000
in cash to this consultant. These amounts are amortized over the life of the
consulting agreement of four months, resulting in consulting expense of $97,000
for the nine months ended September 30, 2005. In November 2005, this consultant
received another 225,000 shares of common stock valued at $85,500 based on the
closing market price of the Company's common stock on the date of the agreement.
The shares were issued pursuant to the exemption from registration under Section
4(2) of the Securities Act. The consultant received information concerning the
Company and had the opportunity to ask questions concerning the Company. The
shares issued contain a legend restricting transferability absent registration
or applicable exemption.

On July 1, 2005, the Company entered into a consulting agreement and
agreed to issue 15,000 shares for services performed by a consultant, which were

II-3

valued at $7,650. The shares were issued pursuant to the exemption from
registration under Section 4(2) of the Securities Act. The service provider
received information concerning the Company and had the opportunity to ask
questions concerning the Company. The shares issued contain a legend restricting
transferability absent registration or applicable exemption.

In January 2006, the Company issued 100,000 shares of common stock to a
consultant, valued at $40,000, which is based on the closing market price of the
Company's common stock on the date of the agreement. The issuances were exempt
from registration under Section 4(2) of the Securities Act. The investors
received information concerning the Company and had the opportunity to ask
questions concerning the viability of the Company. The shares contain legends
restricting their transferability absent registration or applicable exemption.

In August 2006, the Company issued 100,000 shares of common stock to a
consultant, valued at $40,000, which is based on the closing market price of the
Company's common stock on the date of the agreement. In November 2006, the
Company issued 100,000 shares of common stock to a consultant, valued at
$45,000, which is based on the closing market price of the Company's common
stock on the date of the agreement. The issuances were exempt from registration
under Section 4(2) of the Securities Act. The investors received information
concerning the Company and had the opportunity to ask questions concerning the
viability of the Company. The shares contain legends restricting their
transferability absent registration or applicable exemption.

During the twelve months ended December 30, 2006 the Company sold
2,232,500 shares of common stock for $0.40 per share in a private placement
offering to 18 accredited investors. Total proceeds from the sale were $893,000.
The issuances were exempt from registration under Section 4(2) of the Securities
Act. The investors received information concerning the Company and had the
opportunity to ask questions concerning the viability of the Company. The shares
contain legends restricting their transferability absent registration or
applicable exemption.

ITEM 27. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES

Exhibit No. Description of Document
----------- -----------------------

2.1 Agreement and Plan of Reorganization dated May 1996 (1)

3.1 Articles of Incorporation, as amended (1)

3.2 Bylaws (1)

4.1 Form of Stock Certificate (1)

5.1 Opinion of Arnstein & Lehr LLP (to be filed by amendment)

II-4

10.1 Form of Warrant Agreement (filed herein)

10.2 Form of Option Agreement (filed herein)

16.1 Letter from former independent accountant (2)

23.1 Consent of Current Independent Auditor (filed herein)

23.2 Consent of Arnstein & Lehr LLP (included in exhibit 5.1)

(1) Previously filed on Form 10SB Registration Statement, as amended, on
January 19, 2000 (file 000-30454).
(2) Previously filed on Form 8-K Current Report dated March 14, 2005.

ITEM 28. UNDERTAKINGS

The undersigned Registrant undertakes:

(1) To file, during any period in which offers or sales are being made, a
post-effective amendment to this registration statement:

(i) To include any prospectus required by section 10(a)(3) of
the Securities Act of 1933;

(ii) To reflect in the prospectus any facts or events arising
after the effective date of the registration statement (or the
most recent post-effective amendment thereof) which, individually
or in the aggregate, represent a fundamental change in the
information set forth in the registration statement;

(iii) To include any material information with respect to the
plan of distribution not previously disclosed in the registration
statement or any material change to such information in the
registration statement;

Provided, however, that paragraphs (a)(1)(i) and (a)(1)(ii) do not
apply if the registration statement is on Form S-3 or Form S-8, and the
information required to be included in a post-effective amendment by those
paragraphs is contained in periodic reports filed by the registrant pursuant to
section 13 or section 15(d) of the Securities Exchange Act of 1934 that are
incorporated by reference in the registration statement.

(2) That, for the purpose of determining any liability under the Securities Act
of 1933, each such post-effective amendment shall be deemed to be a new
registration statement relating to the securities offered therein, and the
offering of such securities at that time shall be deemed to be the initial bona
fide offering thereof.

(3) To remove from registration by means of a post-effective amendment any of
the securities being registered which remain unsold at the termination of the
offering.

Insofar as indemnification for liabilities arising under the Securities
Act of 1933 (the "Securities Act") may be permitted to directors, officers and
controlling persons of the registrant pursuant to the foregoing provisions, or
otherwise, the Registrant has been advised that in the opinion of the Securities
and Exchange Commission (the "Commission") such indemnification is against
public policy as expressed in the Securities Act and is, therefore,
unenforceable. In the event that a claim for indemnification against such
liabilities (other than the payment by the Registrant of expenses incurred or
paid by a director, officer or controlling person of the Registrant in the

II-5

successful defense of any action, suit or preceding) is asserted by such
director, officer or controlling person in connection with the securities being
registered, the Registrant will, unless in the opinion of its counsel the matter
has been settled by controlling precedent, submit to a court of appropriate
jurisdiction the question whether such indemnification by it is against public
policy as expressed in the Securities Act and will be governed by the final
adjudication of such issue.

Each prospectus filed pursuant to Rule 424(b) as part of a registration
statement relating to an offering, other than registration statements relying on
Rule 430B or other than prospectuses filed in reliance on Rule 430A, shall be
deemed to be part of and included in the registration statement as of the date
it is first used after effectiveness. Provided, however, that no statement made
in a registration statement or prospectus that is part of the registration
statement or made in a document incorporated or deemed incorporated by reference
into the registration statement or prospectus that is part of the registration
statement will, as to a purchaser with a time of contract of sale prior to such
first use, supersede or modify any statement that was made in the registration
statement or prospectus that was part of the registration statement or made in
any such document immediately prior to such date of first use.

II-6

SIGNATURES

Pursuant to the requirements of the Securities Act of 1933, as amended,
the registrant certifies that it has reasonable grounds to believe that it meets
all of the requirements for filing on this Form SB-2 and authorized this
registration statement to be signed on its behalf by the undersigned, thereunto
duly authorized, in Fort Lauderdale, Florida on February 26, 2007.

ENVIRO VORAXIAL TECHNOLOGY, INC.

By:/s/ Alberto Dibella
----------------------
Alberto DiBella, Chief Executive Officer

Pursuant to the requirements of the Securities Act of 1933, this
registration statement has been signed by the following persons in the
capacities and on the dates indicated.

Signature Title Date
--------- ----- ----

/s/Alberto DiBella Chief Executive Officer February 26, 2007
------------------ (principal executive officer)
Alberto DiBella and Chief Financial Officer
(principal financial and
accounting officer)

/s/John A. DiBella Vice President February 26, 2007
------------------
John A. DiBella

II-7